<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">JTO Clin Res Rep</journal-id><journal-id journal-id-type="iso-abbrev">JTO Clin Res Rep</journal-id><journal-id journal-id-type="pmc-domain-id">4097</journal-id><journal-id journal-id-type="pmc-domain">jtocrr</journal-id><journal-title-group><journal-title>JTO Clinical and Research Reports</journal-title></journal-title-group><issn pub-type="epub">2666-3643</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10015251</article-id><article-id pub-id-type="pmcid-ver">PMC10015251.1</article-id><article-id pub-id-type="pmcaid">10015251</article-id><article-id pub-id-type="pmcaiid">10015251</article-id><article-id pub-id-type="pmid">36938372</article-id><article-id pub-id-type="doi">10.1016/j.jtocrr.2023.100469</article-id><article-id pub-id-type="pii">S2666-3643(23)00008-5</article-id><article-id pub-id-type="publisher-id">100469</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Interventions Designed to Increase the Uptake of Lung Cancer Screening: An Equity-Oriented Scoping Review</article-title></title-group><contrib-group><contrib contrib-type="author" id="au1"><name name-style="western"><surname>Sayani</surname><given-names initials="A">Ambreen</given-names></name><degrees>MD, PhD</degrees><email>ambreen.sayani@wchospital.ca</email><xref rid="aff1" ref-type="aff">a</xref><xref rid="aff2" ref-type="aff">b</xref><xref rid="cor1" ref-type="corresp">&#8727;</xref></contrib><contrib contrib-type="author" id="au2"><name name-style="western"><surname>Ali</surname><given-names initials="MA">Muhanad Ahmed</given-names></name><degrees>MA</degrees><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au3"><name name-style="western"><surname>Dey</surname><given-names initials="P">Pooja</given-names></name><degrees>BSc</degrees><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au4"><name name-style="western"><surname>Corrado</surname><given-names initials="AM">Ann Marie</given-names></name><degrees>MSc</degrees><xref rid="aff3" ref-type="aff">c</xref></contrib><contrib contrib-type="author" id="au5"><name name-style="western"><surname>Ziegler</surname><given-names initials="C">Carolyn</given-names></name><degrees>MS</degrees><xref rid="aff4" ref-type="aff">d</xref></contrib><contrib contrib-type="author" id="au6"><name name-style="western"><surname>Nicholson</surname><given-names initials="E">Erika</given-names></name><degrees>MHSc</degrees><xref rid="aff5" ref-type="aff">e</xref></contrib><contrib contrib-type="author" id="au7"><name name-style="western"><surname>Lofters</surname><given-names initials="A">Aisha</given-names></name><degrees>MD, PhD, CCFP</degrees><xref rid="aff1" ref-type="aff">a</xref><xref rid="aff2" ref-type="aff">b</xref><xref rid="aff3" ref-type="aff">c</xref><xref rid="aff6" ref-type="aff">f</xref><xref rid="aff7" ref-type="aff">g</xref><xref rid="aff8" ref-type="aff">h</xref><xref rid="aff9" ref-type="aff">i</xref></contrib><aff id="aff1"><label>a</label>Women&#8217;s College Research Institute, Women&#8217;s College Hospital, Toronto, Ontario, Canada</aff><aff id="aff2"><label>b</label>MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael&#8217;s Hospital, Toronto, Ontario, Canada</aff><aff id="aff3"><label>c</label>Peter Gilgan Centre for Women&#8217;s Cancers, Women&#8217;s College Hospital, Toronto, Ontario, Canada</aff><aff id="aff4"><label>d</label>Library Services, Unity Health Toronto, Toronto, Ontario, Canada</aff><aff id="aff5"><label>e</label>Canadian Partnership Against Cancer, Canada</aff><aff id="aff6"><label>f</label>Institute for Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada</aff><aff id="aff7"><label>g</label>Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada</aff><aff id="aff8"><label>h</label>Department of Family Medicine, Women&#8217;s College Hospital, Toronto, Ontario, Canada</aff><aff id="aff9"><label>i</label>Dalla Lana School of Public Health, University of Toronto, Ontario, Canada</aff></contrib-group><author-notes><corresp id="cor1"><label>&#8727;</label>Corresponding author. Address for correspondence: Ambreen Sayani, MD, PhD, Women&#8217;s College Research Institute, Women&#8217;s College Hospital, 76 Grenville St., Toronto, ON M5S 1B2, Canada. <email>ambreen.sayani@wchospital.ca</email></corresp></author-notes><pub-date pub-type="collection"><month>3</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>02</day><month>2</month><year>2023</year></pub-date><volume>4</volume><issue>3</issue><issue-id pub-id-type="pmc-issue-id">430434</issue-id><elocation-id>100469</elocation-id><history><date date-type="received"><day>14</day><month>9</month><year>2022</year></date><date date-type="rev-recd"><day>17</day><month>1</month><year>2023</year></date><date date-type="accepted"><day>23</day><month>1</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>02</day><month>02</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>16</day><month>03</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-03-20 10:10:24.700"><day>20</day><month>03</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>&#169; 2023 The Authors</copyright-statement><copyright-year>2023</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="main.pdf"/><abstract id="abs0010"><sec><title>Introduction</title><p>Participation in lung cancer screening (LCS) is lower in populations with the highest burden of lung cancer risk (through the social patterning of smoking behavior) and lowest levels of health care utilization (through structurally inaccessible care) leading to a widening of health inequities.</p></sec><sec><title>Methods</title><p>We conducted a scoping review using the Arksey and O&#8217;Malley methodological framework to inform equitable access to LCS by illuminating knowledge and implementation gaps in interventions designed to increase the uptake of LCS. We comprehensively searched for LCS interventions (Ovid Medline, Excerpta Medica database, the Cochrane Library, Cumulative Index to Nursing and Allied Health Literature, and Scopus from 2000 to June 22, 2021) and included peer-reviewed articles and gray literature published in the English language that describe an intervention designed to increase the uptake of LCS, charted data using our previously published tool and conduced a health equity analysis to determine the intended-unintended and positive-negative outcomes of the interventions for populations experiencing the greatest inequities.</p></sec><sec><title>Results</title><p>Our search yielded 3572 peer-reviewed articles and 54,292 pieces of gray literature. Ultimately, we included 35 peer-reviewed articles and one gray literature. The interventions occurred in the United States, United Kingdom, Japan, and Italy, focusing on shared decision-making, the use of electronic health records as reminders, patient navigation, community-based campaigns, and mobile computed tomography scanners. We developed an equity-oriented LCS framework and mapped the dimensions and outcomes of the interventions on access to LCS on the basis of approachability, acceptability, availability, affordability, and appropriateness of the intervention. No intervention was mapped across all five dimensions. Most notably, knowledge and implementation gaps were identified in dimensions of acceptability, availability, and affordability.</p></sec><sec><title>Conclusions</title><p>Interventions that were most effective in improving access to LCS targeted priority populations, raised community-level awareness, tailored materials for sociocultural acceptability, did not depend on prior patient engagement/registration with the health care system, proactively considered costs related to participation, and enhanced utilization through informed decision-making.</p></sec></abstract><kwd-group id="kwrds0010"><title>Keywords</title><kwd>Lung cancer screening</kwd><kwd>Priority population</kwd><kwd>Scoping review</kwd><kwd>Health equity</kwd><kwd>Equity-oriented lung cancer screening framework</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="sec1"><title>Introduction</title><p id="p0010">Lung cancer is one of the most typically diagnosed cancers and is responsible for approximately 20% of all cancer-related deaths across the globe.<xref rid="bib1" ref-type="bibr"><sup>1</sup></xref> Reducing the population burden of lung cancer is a high-priority action area for several health systems and screening techniques such as low-dose computed tomography (LDCT) are increasingly being used to detect early-stage lung cancers that are amenable to treatment. Owing to the results of the sufficiently powered randomized controlled trials (the National Lung Screening Trial<xref rid="bib2" ref-type="bibr"><sup>2</sup></xref> and the Dutch-Belgian&#160;Lung Cancer Screening trial [NELSON] trial<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref>), which found a 20% to 24% mortality benefit from lung screening in high-risk smokers, organized lung cancer screening (LCS) programs have been initiated in several countries including Canada, the United States, South Korea, and Poland, with more regional pilot programs expanding across the United Kingdom, Germany, the Netherlands, and Italy.<xref rid="bib4" ref-type="bibr"><sup>4</sup></xref></p><p id="p0015">LCS with LDCT has been found to reduce mortality linked to NSCLC such as adenocarcinomas, squamous cell carcinomas, and large cell carcinoma that comprise up to 85% of all lung cancer subtypes, which are frequently associated with a history of smoking. Accordingly, LCS is offered to individuals identified as high-risk on the basis of age and smoking history (such as the U.S. Preventive Services Task Force [USPSTF] LCS guidelines, through which individuals over the age of 50 years with &#10878;20 pack-years smoking history qualify for screening<xref rid="bib5" ref-type="bibr"><sup>5</sup></xref>), or on the basis of prediction models that calculate the risk of developing lung cancer over time (of which the prostate lung colorectal and ovarian [PLCOm2012] model is the most widely used<xref rid="bib4" ref-type="bibr"><sup>4</sup></xref>).</p><p id="p0020">Despite the increased emphasis placed on the opportunity to screen for early-stage lung cancer with LDCT, the uptake and participation in screening have been low and have not been uniform across all at-risk groups.<xref rid="bib6" ref-type="bibr">6</xref>, <xref rid="bib7" ref-type="bibr">7</xref>, <xref rid="bib8" ref-type="bibr">8</xref>, <xref rid="bib9" ref-type="bibr">9</xref>, <xref rid="bib10" ref-type="bibr">10</xref> For instance, individuals from lower income groups are almost twice as likely to refrain from LCS despite qualifying as high-risk.<xref rid="bib11" ref-type="bibr"><sup>11</sup></xref> Structurally marginalized populations, women, people who currently smoke, and those who are older or have multiple comorbidities are also less likely to participate in LCS.<xref rid="bib11" ref-type="bibr"><sup>11</sup></xref> Housing insecure populations, in particular, participate less frequently in LCS<xref rid="bib12" ref-type="bibr">12</xref>, <xref rid="bib13" ref-type="bibr">13</xref>, <xref rid="bib14" ref-type="bibr">14</xref> because of multiple challenges in accessing health care such as transportation, competing priorities, comorbidities,<xref rid="bib15" ref-type="bibr"><sup>15</sup></xref> experiences of stigma and mistrust of health providers.<xref rid="bib13" ref-type="bibr"><sup>13</sup></xref><sup>,</sup><xref rid="bib16" ref-type="bibr"><sup>16</sup></xref> This is of significance because the socioeconomic gradient in lung cancer risk, incidence, and mortality<xref rid="bib17" ref-type="bibr"><sup>17</sup></xref><sup>,</sup><xref rid="bib18" ref-type="bibr"><sup>18</sup></xref> follow patterns of structured social disadvantage leading to sharp distinctions across population groups. Smoking behaviors and access to care,<xref rid="bib13" ref-type="bibr"><sup>13</sup></xref><sup>,</sup><xref rid="bib14" ref-type="bibr"><sup>14</sup></xref> for example, are shaped by the social determinants of health and how they intersect with social identity to mediate social position (described as the intersectional rank order an individual occupies in society determined by the availability of material resources and social structures that create classism, ableism, and racism<xref rid="bib19" ref-type="bibr"><sup>19</sup></xref>).</p><p id="p0025">The proactive outreach and redistribution of resources and services to match health needs in populations experiencing the highest burden of illness is described as a &#8220;priority population&#8221; approach.<xref rid="bib20" ref-type="bibr"><sup>20</sup></xref> Concerning LCS, priority populations are populations at highest risk of developing lung cancer (on the basis of smoking history) and those experiencing the greatest barriers to participation in LCS (because of social circumstances that create economic, structural, and geographic barriers to care and stigma associated with smoking).<xref rid="bib21" ref-type="bibr"><sup>21</sup></xref> Indigenous communities in countries such as Canada, Australia, and New Zealand suffer from disproportionate burdens of lung cancer risk and inequitable access to care, from the unjust, and discriminatory effects of colonization. In such countries, indigenous communities are considered priority populations for LCS.<xref rid="bib22" ref-type="bibr"><sup>22</sup></xref> Equity-oriented LCS can increase the uptake of LDCT in populations with the highest burden of risk and can promote more equitable health outcomes. However, little is currently known about the design and scope of interventions designed to increase the uptake of LCS and the impact of such interventions on priority populations (intended-unintended or positive-negative). This knowledge can inform the implementation of future equity-oriented LCS interventions so that we can reduce the socioeconomic gradient in lung cancer mortality.</p></sec><sec id="sec2"><title>Materials and Methods</title><p id="p0030">We conducted a scoping review in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis extension for Scoping Reviews<xref rid="bib23" ref-type="bibr"><sup>23</sup></xref> and the six-stage methodological framework developed by Arksey and O&#8217;Malley.<xref rid="bib24" ref-type="bibr"><sup>24</sup></xref> We retrieved data from the publicly available literature. Accordingly, we did not require research ethics board approval or informed consent. To enhance methodologic rigor, we have published our peer-reviewed study protocol earlier<xref rid="bib21" ref-type="bibr"><sup>21</sup></xref> and now describe in detail the processes that we undertook:</p><sec id="sec2.1"><title>Research Questions</title><p id="p0035">The research team consists of policy makers involved with the implementation of LCS at the Canadian provincial (AL) and federal (EN) levels, health service researchers with methodological expertise in scoping reviews (AS, AL, MA, PD), health equity (AS, AL), inequalities in cancer care (AS) and a health sciences librarian (CZ). We sought to answer the following research questions:<list list-type="simple" id="olist0010"><list-item id="o0010"><label>1.</label><p id="p0040">What interventions have been implemented to increase the uptake of LCS in the Organisation for Economic Cooperation and Development countries (including study design, population, nature of the intervention, and outcome measures), and were these interventions effective?</p></list-item><list-item id="o0015"><label>2.</label><p id="p0045">What are the impacts of the intervention (intended/unintended and positive/negative) on access to LCS for priority populations?</p></list-item><list-item id="o0020"><label>3.</label><p id="p0050">What knowledge and implementation gaps can we identify to inform the equitable design of LCS?</p></list-item></list></p></sec><sec id="sec2.2"><title>Search Strategy</title><p id="p0055">We conducted database searches in Medline (Ovid), Excerpta Medica dataBASE (Ovid), Cochrane Central Register of Controlled Trials and Cochrane Database of Systematic Reviews (Ovid), Cumulative Index to Nursing and Allied Health Literature (Elton B. Stephens Company Information Services), and Scopus. We used a comprehensive combination of subject headings and keywords, adapted for each database, for the concepts of LCS and health promotion interventions (<xref rid="appsec1" ref-type="sec">Supplementary Material 1</xref>). The databases were searched from 2000 to June 22, 2021, and were limited to English publications. We identified gray literature (policy documents and reports) by searching government and institutional websites (given that LCS trials with LDCT began in the early 2000s). All titles, abstracts, and full texts were independently screened by two teams of reviewers (MA, PD, and two research students) using Covidence<xref rid="bib25" ref-type="bibr"><sup>25</sup></xref> to identify the articles for data extraction. Abstracts, study protocols, and conference proceedings which described an intervention designed to increase the uptake of LCS were included. Literature that did not describe documented interventions to increase participation in LCS was excluded. Discrepancies were resolved through consultation as a study team.</p></sec><sec id="sec2.3"><title>Data Extraction</title><p id="p0060">Data were extracted from all retrieved articles (peer-reviewed and gray literature) using a unique chart adapted from the Template for Intervention Description and Republication checklist,<xref rid="bib26" ref-type="bibr"><sup>26</sup></xref> the CONSORT,<xref rid="bib27" ref-type="bibr"><sup>27</sup></xref> and the Ontario Ministry of Health&#8217;s Health Equity Impact Assessment (HEIA) tool.<xref rid="bib28" ref-type="bibr"><sup>28</sup></xref> Details of this chart can be read elsewhere.<xref rid="bib21" ref-type="bibr"><sup>21</sup></xref> Initially, two members of the research team (MA, PD) independently charted the Template for Intervention Description and Republication and CONSORT data for the first three articles followed by a full team review and discussion for consensus building. Subsequently, the remaining articles were distributed (between MA and PD) for full extraction. Team members (MA, PD) received training on how to use the HEIA tool (by AS). The HEIA of all data was conducted through a series of team workshops (led by AS, charted by MA, and PD with input from EN and oversight from AL).</p></sec><sec id="sec2.4"><title>Data Synthesis and Reporting</title><p id="p0065">Data were synthesized using the &#8220;Patient-Centered Access to Healthcare&#8221; conceptual framework,<xref rid="bib29" ref-type="bibr"><sup>29</sup></xref><sup>,</sup><xref rid="bib30" ref-type="bibr"><sup>30</sup></xref> which we adapted to map the dimensions and outcomes of access to LCS on the basis of the structural and social determinants of health. In doing so, we developed a new equity-oriented LCS framework (<xref rid="fig1" ref-type="fig">Fig.&#160;1</xref>) and used it to illustrate knowledge and implementation gaps. Using the equity-oriented LCS framework, we define access (opportunity to have individual health care needs met) to LCS as the opportunity to reduce lung cancer mortality amenable to LCS interventions and we describe the dimensions of accessibility in relation to LCS as:<list list-type="simple" id="olist0015"><list-item id="o0025"><label>1.</label><p id="p0070">Approachability: The existence of LCS services that are known to communities at risk;</p></list-item><list-item id="o0030"><label>2.</label><p id="p0075">Acceptability: The social and cultural factors determining participation in LCS;</p></list-item><list-item id="o0035"><label>3.</label><p id="p0080">Availability: The ability to reach and do LCS in a timely way;</p></list-item><list-item id="o0040"><label>4.</label><p id="p0085">Affordability: The direct (cost of LDCT) and indirect (lost income opportunity/transportation) financial capacity to utilize LCS;</p></list-item><list-item id="o0045"><label>5.</label><p id="p0090">Appropriateness: The fit between need and utilization determined by informed decision-making, empowerment to engage, and adherence to LDCT.</p></list-item></list><fig id="fig1" position="float" orientation="portrait"><label>Figure&#160;1</label><caption><p>Equity-oriented lung cancer screening framework. LDCT, low-dose computed tomography.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr1.jpg"/></fig></p></sec></sec><sec id="sec3"><title>Results</title><sec id="sec3.1"><title>Search Results</title><p id="p0095">The search results are outlined in <xref rid="fig2" ref-type="fig">Figure&#160;2</xref>. A total of 3572 peer-reviewed articles were eligible for review. There were 3401 articles excluded on the title review, 169 on the abstract review, and a further 79 after reading full texts (yielding 33 articles), and one dissertation that met the inclusion criteria. One additional peer-reviewed publication was identified through citations and included (See <xref rid="appsec1" ref-type="sec">Supplementary Material 1</xref> for the peer-reviewed search strategies). Ultimately, 34 peer-reviewed articles and one dissertation were included. The gray literature search strategy (<xref rid="appsec1" ref-type="sec">Supplementary Material 2</xref>) was intentionally broad to capture any interventions that were currently ongoing but not yet captured in published peer-reviewed literature. Subsequently, we retrieved 54,292 gray literature articles, excluded 54,253 on the basis of title review, and 39 further articles were excluded on review of the executive summary and table of contents resulting in three articles that met the study inclusion criteria. Two of these articles were duplicated in the review of peer-reviewed literature and, therefore, not included in data extraction and synthesis. Ultimately, one gray literature article was included. A total of 36 records were included for analysis and synthesis.<fig id="fig2" position="float" orientation="portrait"><label>Figure&#160;2</label><caption><p>Article selection flow chart. CINAHL, Cumulative Index to Nursing and Allied Health Literature; EMBASE, Excerpta Medica database; MEDLINE, Medical Literature Analysis and Retrieval System Online.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr2.jpg"/></fig></p></sec><sec id="sec3.2"><title>Description of Interventions Designed to Increase the Uptake of LCS</title><p id="p0100">Of the 36 interventions described in the literature (<xref rid="tbl1" ref-type="table">Tables 1</xref> and <xref rid="tbl2" ref-type="table">2</xref>), 26 studies were conducted in the United States,<xref rid="bib31" ref-type="bibr">31</xref>, <xref rid="bib32" ref-type="bibr">32</xref>, <xref rid="bib33" ref-type="bibr">33</xref>, <xref rid="bib34" ref-type="bibr">34</xref>, <xref rid="bib35" ref-type="bibr">35</xref>, <xref rid="bib36" ref-type="bibr">36</xref>, <xref rid="bib37" ref-type="bibr">37</xref>, <xref rid="bib38" ref-type="bibr">38</xref>, <xref rid="bib39" ref-type="bibr">39</xref>, <xref rid="bib40" ref-type="bibr">40</xref>, <xref rid="bib41" ref-type="bibr">41</xref>, <xref rid="bib42" ref-type="bibr">42</xref>, <xref rid="bib43" ref-type="bibr">43</xref>, <xref rid="bib44" ref-type="bibr">44</xref>, <xref rid="bib45" ref-type="bibr">45</xref>, <xref rid="bib46" ref-type="bibr">46</xref>, <xref rid="bib47" ref-type="bibr">47</xref>, <xref rid="bib48" ref-type="bibr">48</xref>, <xref rid="bib49" ref-type="bibr">49</xref>, <xref rid="bib50" ref-type="bibr">50</xref>, <xref rid="bib51" ref-type="bibr">51</xref>, <xref rid="bib52" ref-type="bibr">52</xref>, <xref rid="bib53" ref-type="bibr">53</xref>, <xref rid="bib54" ref-type="bibr">54</xref>, <xref rid="bib55" ref-type="bibr">55</xref>, <xref rid="bib56" ref-type="bibr">56</xref> eight in the United Kingdom,<xref rid="bib57" ref-type="bibr">57</xref>, <xref rid="bib58" ref-type="bibr">58</xref>, <xref rid="bib59" ref-type="bibr">59</xref>, <xref rid="bib60" ref-type="bibr">60</xref>, <xref rid="bib61" ref-type="bibr">61</xref>, <xref rid="bib62" ref-type="bibr">62</xref>, <xref rid="bib63" ref-type="bibr">63</xref>, <xref rid="bib64" ref-type="bibr">64</xref> one in&#160;Japan,<xref rid="bib65" ref-type="bibr"><sup>65</sup></xref> and one in Italy.<xref rid="bib66" ref-type="bibr"><sup>66</sup></xref> Articles described 10 randomized control,<xref rid="bib33" ref-type="bibr"><sup>33</sup></xref><sup>,</sup><xref rid="bib34" ref-type="bibr"><sup>34</sup></xref><sup>,</sup><xref rid="bib39" ref-type="bibr"><sup>39</sup></xref><sup>,</sup><xref rid="bib42" ref-type="bibr"><sup>42</sup></xref><sup>,</sup><xref rid="bib45" ref-type="bibr"><sup>45</sup></xref><sup>,</sup><xref rid="bib47" ref-type="bibr"><sup>47</sup></xref><sup>,</sup><xref rid="bib52" ref-type="bibr"><sup>52</sup></xref><sup>,</sup><xref rid="bib58" ref-type="bibr"><sup>58</sup></xref><sup>,</sup><xref rid="bib62" ref-type="bibr"><sup>62</sup></xref><sup>,</sup><xref rid="bib65" ref-type="bibr"><sup>65</sup></xref> 11 descriptive,<xref rid="bib35" ref-type="bibr"><sup>35</sup></xref><sup>,</sup><xref rid="bib43" ref-type="bibr"><sup>43</sup></xref><sup>,</sup><xref rid="bib44" ref-type="bibr"><sup>44</sup></xref><sup>,</sup><xref rid="bib54" ref-type="bibr"><sup>54</sup></xref><sup>,</sup><xref rid="bib57" ref-type="bibr"><sup>57</sup></xref><sup>,</sup><xref rid="bib59" ref-type="bibr">59</xref>, <xref rid="bib60" ref-type="bibr">60</xref>, <xref rid="bib61" ref-type="bibr">61</xref><sup>,</sup><xref rid="bib63" ref-type="bibr"><sup>63</sup></xref><sup>,</sup><xref rid="bib64" ref-type="bibr"><sup>64</sup></xref><sup>,</sup><xref rid="bib66" ref-type="bibr"><sup>66</sup></xref> seven pre and posttest,<xref rid="bib31" ref-type="bibr"><sup>31</sup></xref><sup>,</sup><xref rid="bib37" ref-type="bibr"><sup>37</sup></xref><sup>,</sup><xref rid="bib40" ref-type="bibr"><sup>40</sup></xref><sup>,</sup><xref rid="bib46" ref-type="bibr"><sup>46</sup></xref><sup>,</sup><xref rid="bib48" ref-type="bibr"><sup>48</sup></xref><sup>,</sup><xref rid="bib49" ref-type="bibr"><sup>49</sup></xref><sup>,</sup><xref rid="bib53" ref-type="bibr"><sup>53</sup></xref> three retrospective,<xref rid="bib36" ref-type="bibr"><sup>36</sup></xref><sup>,</sup><xref rid="bib38" ref-type="bibr"><sup>38</sup></xref><sup>,</sup><xref rid="bib51" ref-type="bibr"><sup>51</sup></xref> and four prospective<xref rid="bib32" ref-type="bibr"><sup>32</sup></xref><sup>,</sup><xref rid="bib41" ref-type="bibr"><sup>41</sup></xref><sup>,</sup><xref rid="bib50" ref-type="bibr"><sup>50</sup></xref><sup>,</sup><xref rid="bib56" ref-type="bibr"><sup>56</sup></xref> studies. Fifteen interventions were centered around decision-making for LCS, focusing specifically on shared decision-making (SDM) sessions<xref rid="bib31" ref-type="bibr"><sup>31</sup></xref><sup>,</sup><xref rid="bib32" ref-type="bibr"><sup>32</sup></xref><sup>,</sup><xref rid="bib37" ref-type="bibr"><sup>37</sup></xref> and, or the use of decision aids, educational tools, and outreach materials.<xref rid="bib39" ref-type="bibr">39</xref>, <xref rid="bib40" ref-type="bibr">40</xref>, <xref rid="bib41" ref-type="bibr">41</xref>, <xref rid="bib42" ref-type="bibr">42</xref><sup>,</sup><xref rid="bib45" ref-type="bibr"><sup>45</sup></xref><sup>,</sup><xref rid="bib48" ref-type="bibr"><sup>48</sup></xref><sup>,</sup><xref rid="bib50" ref-type="bibr"><sup>50</sup></xref><sup>,</sup><xref rid="bib52" ref-type="bibr"><sup>52</sup></xref><sup>,</sup><xref rid="bib58" ref-type="bibr"><sup>58</sup></xref><sup>,</sup><xref rid="bib62" ref-type="bibr"><sup>62</sup></xref><sup>,</sup><xref rid="bib63" ref-type="bibr"><sup>63</sup></xref><sup>,</sup><xref rid="bib65" ref-type="bibr"><sup>65</sup></xref> Interventions also focused on the use of electronic health records as a tool to reach eligible patients. Of these, two interventions prompted patients directly to seek risk assessment<xref rid="bib33" ref-type="bibr"><sup>33</sup></xref><sup>,</sup><xref rid="bib35" ref-type="bibr"><sup>35</sup></xref> and others generated clinical prompts and reminders for health care providers in the primary care setting.<xref rid="bib36" ref-type="bibr"><sup>36</sup></xref><sup>,</sup><xref rid="bib49" ref-type="bibr"><sup>49</sup></xref><sup>,</sup><xref rid="bib56" ref-type="bibr"><sup>56</sup></xref><sup>,</sup><xref rid="bib62" ref-type="bibr"><sup>62</sup></xref> Eight studies described community-based interventions, including community-based campaigns<xref rid="bib34" ref-type="bibr"><sup>34</sup></xref><sup>,</sup><xref rid="bib46" ref-type="bibr"><sup>46</sup></xref><sup>,</sup><xref rid="bib66" ref-type="bibr"><sup>66</sup></xref> and/or the use of mobile computed tomography scanners.<xref rid="bib54" ref-type="bibr"><sup>54</sup></xref><sup>,</sup><xref rid="bib57" ref-type="bibr"><sup>57</sup></xref><sup>,</sup><xref rid="bib60" ref-type="bibr"><sup>60</sup></xref><sup>,</sup><xref rid="bib61" ref-type="bibr"><sup>61</sup></xref><sup>,</sup><xref rid="bib64" ref-type="bibr"><sup>64</sup></xref> Ten studies described interventions that facilitated navigation to LCS through nurses,<xref rid="bib53" ref-type="bibr"><sup>53</sup></xref><sup>,</sup><xref rid="bib55" ref-type="bibr"><sup>55</sup></xref><sup>,</sup><xref rid="bib56" ref-type="bibr"><sup>56</sup></xref> program navigators,<xref rid="bib39" ref-type="bibr"><sup>39</sup></xref><sup>,</sup><xref rid="bib43" ref-type="bibr"><sup>43</sup></xref><sup>,</sup><xref rid="bib44" ref-type="bibr"><sup>44</sup></xref><sup>,</sup><xref rid="bib47" ref-type="bibr"><sup>47</sup></xref><sup>,</sup><xref rid="bib51" ref-type="bibr"><sup>51</sup></xref> or through existing care pathways such as cancer screening<xref rid="bib38" ref-type="bibr"><sup>38</sup></xref> or chronic obstructive pulmonary disease clinics.<xref rid="bib59" ref-type="bibr"><sup>59</sup></xref> Twenty interventions described in the literature included a smoking cessation component, such as simultaneous referral to a smoking cessation hotline or referrals to nicotine dependence clinics or services for people who currently smoke.<xref rid="bib31" ref-type="bibr"><sup>31</sup></xref><sup>,</sup><xref rid="bib38" ref-type="bibr"><sup>38</sup></xref><sup>,</sup><xref rid="bib41" ref-type="bibr">41</xref>, <xref rid="bib42" ref-type="bibr">42</xref>, <xref rid="bib43" ref-type="bibr">43</xref>, <xref rid="bib44" ref-type="bibr">44</xref><sup>,</sup><xref rid="bib46" ref-type="bibr">46</xref>, <xref rid="bib47" ref-type="bibr">47</xref>, <xref rid="bib48" ref-type="bibr">48</xref><sup>,</sup><xref rid="bib51" ref-type="bibr">51</xref>, <xref rid="bib52" ref-type="bibr">52</xref>, <xref rid="bib53" ref-type="bibr">53</xref><sup>,</sup><xref rid="bib55" ref-type="bibr">55</xref>, <xref rid="bib56" ref-type="bibr">56</xref>, <xref rid="bib57" ref-type="bibr">57</xref><sup>,</sup><xref rid="bib61" ref-type="bibr">61</xref>, <xref rid="bib62" ref-type="bibr">62</xref>, <xref rid="bib63" ref-type="bibr">63</xref>, <xref rid="bib64" ref-type="bibr">64</xref><sup>,</sup><xref rid="bib66" ref-type="bibr"><sup>66</sup></xref><table-wrap position="float" id="tbl1" orientation="portrait"><label>Table&#160;1</label><caption><p>Overview of Selected Records</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Characteristics</th><th colspan="1" rowspan="1">Output</th></tr></thead><tbody><tr><td rowspan="3" colspan="1">Year</td><td colspan="1" rowspan="1">&#8804; 2017 (n&#160;= 10) (including one gray literature)</td></tr><tr><td colspan="1" rowspan="1">2018 &#8211; 2020 (n&#160;= 22)</td></tr><tr><td colspan="1" rowspan="1">&#8805; 2021 (n&#160;= 4)</td></tr><tr><td rowspan="4" colspan="1">Geography</td><td colspan="1" rowspan="1">United Kingdom (n&#160;= 8)</td></tr><tr><td colspan="1" rowspan="1">Unites States of America (n&#160;= 26) (including one gray literature)</td></tr><tr><td colspan="1" rowspan="1">Japan (n&#160;= 1)</td></tr><tr><td colspan="1" rowspan="1">Italy (n&#160;= 1)</td></tr><tr><td rowspan="3" colspan="1">Record type</td><td colspan="1" rowspan="1">Journal Article (n&#160;= 34)</td></tr><tr><td colspan="1" rowspan="1">Report (n&#160;= 1)</td></tr><tr><td colspan="1" rowspan="1">Dissertation (n&#160;= 1)</td></tr><tr><td rowspan="5" colspan="1">Methodology (for peer-review articles only)</td><td colspan="1" rowspan="1">Randomized control study (n&#160;= 10)</td></tr><tr><td colspan="1" rowspan="1">Descriptive study (n&#160;= 11)</td></tr><tr><td colspan="1" rowspan="1">Pre and posttest study (n&#160;= )</td></tr><tr><td colspan="1" rowspan="1">Retrospective study (n&#160;= )</td></tr><tr><td colspan="1" rowspan="1">Prospective study (n&#160;= )</td></tr><tr><td rowspan="7" colspan="1">Main focus of intervention (some interventions had multiple components)</td><td colspan="1" rowspan="1">SDM (n&#160;= 3)</td></tr><tr><td colspan="1" rowspan="1">Educational tools, decision aids and outreach materials (n&#160;= 12)</td></tr><tr><td colspan="1" rowspan="1">EHR&#8211;patient-facing prompt (2)</td></tr><tr><td colspan="1" rowspan="1">EHR&#8211;provider facing prompt (4)</td></tr><tr><td colspan="1" rowspan="1">Community-based campaign and/or mobile LDCT (n&#160;= 8)</td></tr><tr><td colspan="1" rowspan="1">Patient Navigation&#8211;nurse or navigator (n&#160;= 8)</td></tr><tr><td colspan="1" rowspan="1">Referral through alternate care pathway (n&#160;= 2)</td></tr></tbody></table><table-wrap-foot><fn><p>EHR, electronic health record; LDCT, low-dose computed tomography; SDM, shared decision making.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="tbl2" orientation="portrait"><label>Table&#160;2</label><caption><p>Description of Interventions Designed to Increase the Uptake of LCS</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Author&#8217;s Name</th><th colspan="1" rowspan="1">Year of Publication</th><th colspan="1" rowspan="1">Study Type</th><th colspan="1" rowspan="1">Study Location</th><th colspan="1" rowspan="1">Study Setting</th><th colspan="1" rowspan="1">Proposed Aim Of Study</th><th colspan="1" rowspan="1">Intervention</th><th colspan="1" rowspan="1">Outcome Measures</th><th colspan="1" rowspan="1">Effectiveness</th><th colspan="1" rowspan="1">Smoking Cessation Linked To LCS Intervention</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Fagan et&#160;al.</td><td colspan="1" rowspan="1">2019</td><td colspan="1" rowspan="1">Pre and posttest study</td><td colspan="1" rowspan="1">Delaware, United States</td><td colspan="1" rowspan="1">Academic Health care system&#8211;primary care practice</td><td colspan="1" rowspan="1">To assess the feasibility of a telephone-based SDM process integrated into primary care</td><td colspan="1" rowspan="1">Eligible patients are identified through EMR. DCP software used to guide telephone-based SDM led by a trained decision-counselor</td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0020"><list-item id="o0050"><label>1.</label><p id="p0200">Percentage uptake of LDCT</p></list-item><list-item id="o0055"><label>2.</label><p id="p0205">Association between uptake and DCP completion</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0025"><list-item id="o0060"><label>1.</label><p id="p0210">829 eligible individuals identified by EMR</p></list-item><list-item id="o0065"><label>2.</label><p id="p0215">297 individuals were reachable by telephone out of which 54 were eligible for screening with LDCT</p></list-item><list-item id="o0070"><label>3.</label><p id="p0220">28 participants were recruited to study of which 20 completed SDM</p></list-item><list-item id="o0075"><label>4.</label><p id="p0225">9 participants completed DCP and LDCT</p></list-item></list></td><td colspan="1" rowspan="1">Tobacco cessation hotline offered to all current smokers</td></tr><tr><td colspan="1" rowspan="1">Balata et&#160;al.<xref rid="bib57" ref-type="bibr"><sup>57</sup></xref></td><td colspan="1" rowspan="1">2019</td><td colspan="1" rowspan="1">Nonrandomized study</td><td colspan="1" rowspan="1">United Kingdom</td><td colspan="1" rowspan="1">Retail locations in socioeconomically deprived neighborhoods on the basis of the IMD</td><td colspan="1" rowspan="1">To understand participants' views of the importance of free, community-based, mobile CT screening</td><td colspan="1" rowspan="1">Letters of invitation were sent to age-eligible smokers identified through primary care practices. Individuals who completed two rounds of lung screening were eligible to participate in a self-completed questionnaire</td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0030"><list-item id="o0080"><label>1.</label><p id="p0230">Percentage of participants that found the location to be an important factor for attendance.</p></list-item><list-item id="o0085"><label>2.</label><p id="p0235">Statistical associations between participant demographics and location preference</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0035"><list-item id="o0090"><label>1.</label><p id="p0240">75% stated community-based 'location was important' for LCS participation</p></list-item><list-item id="o0095"><label>2.</label><p id="p0245">25% of participants would not attend LCS if it was hospital-based</p></list-item><list-item id="o0100"><label>3.</label><p id="p0250">Willingness to attend hospital-based LCS significantly decreased with increasing deprivation (IMD rank) and among current smokers</p></list-item></list></td><td colspan="1" rowspan="1">Smoking cessation advice offered during initial intake&#8211;no information about ongoing smoking cessation services provided</td></tr><tr><td colspan="1" rowspan="1">Crosbie et&#160;al.</td><td colspan="1" rowspan="1">2019</td><td colspan="1" rowspan="1">Nonrandomized study</td><td colspan="1" rowspan="1">United Kingdom</td><td colspan="1" rowspan="1">Retail locations in socioeconomically deprived neighborhoods on the basis of the IMD</td><td colspan="1" rowspan="1">To determine the feasibility of a community-based LCDT LCS pilot program</td><td colspan="1" rowspan="1">Letters of invitation were sent to age-eligible smokers identified through primary care practices. Individuals who booked an LHC appointment were assessed for lung cancer risk using the PLCO score. Individuals with PLCO score greater than or equal to 1.51% were offered immediate LDCT screening through a mobile scanner</td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0040"><list-item id="o0105"><label>1.</label><p id="p0255">The statistical association between participant demographics and lung cancer risk (PLCO score)</p></list-item><list-item id="o0110"><label>2.</label><p id="p0260">Percentage of attendees qualifying for LDCT</p></list-item><list-item id="o0115"><label>3.</label><p id="p0265">Number of individuals screened with LDCT</p></list-item><list-item id="o0120"><label>4.</label><p id="p0270">Percentage of lung cancers detected</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0045"><list-item id="o0125"><label>1.</label><p id="p0275">9926 ever-smokers invited by mail of which 28.5% booked an LHC</p></list-item><list-item id="o0130"><label>2.</label><p id="p0280">56.2% of LHC attendees have a PLCO risk score of &gt; 1.51%</p></list-item><list-item id="o0135"><label>3.</label><p id="p0285">96% of eligible attendees received LDCT</p></list-item><list-item id="o0140"><label>4.</label><p id="p0290">3% of attendees had lung cancer identified through the program</p></list-item><list-item id="o0145"><label>5.</label><p id="p0295">75% of attendees were ranked in the lowest deprivation quintile</p></list-item></list></td><td colspan="1" rowspan="1">Smoking cessation advice offered during LHC</td></tr><tr><td colspan="1" rowspan="1">Giamboy<xref rid="bib56" ref-type="bibr"><sup>56</sup></xref></td><td colspan="1" rowspan="1">2017</td><td colspan="1" rowspan="1">Prospective study</td><td colspan="1" rowspan="1">Northeast Philadelphia, United States</td><td colspan="1" rowspan="1">Community health centers to target geographic areas identified as having higher rates of smoking and lung cancer incidence</td><td colspan="1" rowspan="1">To implement an EHR clinical decision support system for nurses that will increase referrals to lung cancer screening</td><td colspan="1" rowspan="1">EHR system modified to flag individuals eligible for referral to LCS. Nurses provide education and refer patients for LDCT. Nurse navigator responsible for identifying and providing further education for patients who are referred but have not yet screened</td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0050"><list-item id="o0150"><label>1.</label><p id="p0300">Number of patient referrals to the LCS program</p></list-item><list-item id="o0155"><label>2.</label><p id="p0305">Number of referrals coming from the nurse pathway</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0055"><list-item id="o0160"><label>1.</label><p id="p0310">In 2016, 15 patients screened</p></list-item><list-item id="o0165"><label>2.</label><p id="p0315">In 2017, 45 patients were screened; of these 25 out of 45 patients were referred by means of the nurse pathway</p></list-item></list></td><td colspan="1" rowspan="1">Tobacco dependence clinic available to all smokers</td></tr><tr><td colspan="1" rowspan="1">Erkmen et&#160;al.<xref rid="bib32" ref-type="bibr"><sup>32</sup></xref></td><td colspan="1" rowspan="1">2018</td><td colspan="1" rowspan="1">Prospective study</td><td colspan="1" rowspan="1">Philadephia, United States</td><td colspan="1" rowspan="1">The clinical setting for minority underserved populations</td><td colspan="1" rowspan="1">To assess the feasibility of guided discussion on willingness and ability to undergo lung cancer treatment during an SDM visit</td><td colspan="1" rowspan="1">Healthcare providers refer patients to the LCS program. Patients undergo SDM sessions with a physician or a physician assistant using an SDM online decision-making website. SDM session, LDCT, and discussion of scan results occur on the same d</td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0060"><list-item id="o0170"><label>1.</label><p id="p0320">Percentage of patients that proceed with LDCT after SDM visit</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0065"><list-item id="o0175"><label>1.</label><p id="p0325">176/179 underwent LDCT screening after the SDM visit</p></list-item></list></td><td colspan="1" rowspan="1">None</td></tr><tr><td colspan="1" rowspan="1">Yoshida et&#160;al.<xref rid="bib65" ref-type="bibr"><sup>65</sup></xref></td><td colspan="1" rowspan="1">2012</td><td colspan="1" rowspan="1">Randomized controlled trial</td><td colspan="1" rowspan="1">Japan</td><td colspan="1" rowspan="1">Municipalities with reported low rates of lung cancer screening</td><td colspan="1" rowspan="1">To evaluate the effectiveness of a leaflet designed to promote participation in LCS</td><td colspan="1" rowspan="1">A leaflet containing educational information related to lung cancer risk and LCS was mailed to the intervention arm. Intervention and control arms received a questionnaire to collect lifestyle information and assess the effectiveness of the leaflet (intervention arm only). All participants returned the questionnaire by means of return envelope attached</td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0070"><list-item id="o0180"><label>1.</label><p id="p0330">Effectiveness of leaflet (measured as a &#8220;yes&#8221; the leaflet is an effective way to motivate participation in LCS</p></list-item><list-item id="o0185"><label>2.</label><p id="p0335">Intervention versus control group LCS rates</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0075"><list-item id="o0190"><label>1.</label><p id="p0340">60% of participants in the intervention arm reported that the leaflet was effective</p></list-item><list-item id="o0195"><label>2.</label><p id="p0345">LCS rates for intervention versus the control group were 38.8% and 37.7%, respectively</p></list-item></list></td><td colspan="1" rowspan="1">None</td></tr><tr><td colspan="1" rowspan="1">Begnaud et&#160;al.<xref rid="bib33" ref-type="bibr"><sup>33</sup></xref></td><td colspan="1" rowspan="1">2017</td><td colspan="1" rowspan="1">Randomized controlled trial</td><td colspan="1" rowspan="1">Minnesota, United States</td><td colspan="1" rowspan="1">Academic health system-Primary care or pulmonary clinics</td><td colspan="1" rowspan="1">To evaluate the impact of targeted electronic messaging through a patient portal to increase LCS uptake in former smokers</td><td colspan="1" rowspan="1">Eligible patients identified by means of EHR. Intervention groups sent electronic messages describing LCS and eligibility through a patient portal. The control group received the usual care</td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0080"><list-item id="o0200"><label>1.</label><p id="p0350">Number of participants who read the electronic message</p></list-item><list-item id="o0205"><label>2.</label><p id="p0355">The number who responded to the message</p></list-item><list-item id="o0210"><label>3.</label><p id="p0360">The number who completed a smoking history</p></list-item><list-item id="o0215"><label>4.</label><p id="p0365">The number who were eligible for screening by self-reported smoking history</p></list-item><list-item id="o0220"><label>5.</label><p id="p0370">Number of screening examinations completed</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0085"><list-item id="o0225"><label>1.</label><p id="p0375">Total of 99 participants in the intervention arm</p></list-item><list-item id="o0230"><label>2.</label><p id="p0380">66 (67%) in the intervention group read the message</p></list-item><list-item id="o0235"><label>3.</label><p id="p0385">24 (36%) of 66 responded to the message</p></list-item><list-item id="o0240"><label>4.</label><p id="p0390">19 (79%) of 24 respondents completed the smoking history.</p></list-item><list-item id="o0245"><label>5.</label><p id="p0395">Four participants underwent screening in the intervention group compared with one participant in the control group</p></list-item></list></td><td colspan="1" rowspan="1">None</td></tr><tr><td colspan="1" rowspan="1">Cardarelli et&#160;al.<xref rid="bib34" ref-type="bibr"><sup>34</sup></xref></td><td colspan="1" rowspan="1">2017</td><td colspan="1" rowspan="1">Randomized controlled trial</td><td colspan="1" rowspan="1">Kentucky, United States</td><td colspan="1" rowspan="1">Community settings with high lung cancer incidence and mortality incidence</td><td colspan="1" rowspan="1">To evaluate the impact of a community-engaged LCS campaign on the uptake of lung cancer screening</td><td colspan="1" rowspan="1">A campaign designed using focus groups with community members. The intervention arm received campaign material consisting of postcards, flyers, television, newspaper, and radio advertisements along with supporting websites. The control arm did not receive the campaign. Telephone surveys were administered in every region to analyze the reach of the campaign and uptake of LDCT assessed</td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0090"><list-item id="o0250"><label>1.</label><p id="p0400">Percentage of survey participants who had been exposed to the campaign in the past 4&#8211;6 mo</p></list-item><list-item id="o0255"><label>2.</label><p id="p0405">Percentage of those exposed to the campaign who reported taking action in response to the campaign</p></list-item><list-item id="o0260"><label>3.</label><p id="p0410">Percentage of LDCT uptake in each region</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0095"><list-item id="o0265"><label>1.</label><p id="p0415">50.3% of survey participants have been exposed to the campaign</p></list-item><list-item id="o0270"><label>2.</label><p id="p0420">83.6% of those exposed to the campaign reported taking some action</p></list-item><list-item id="o0275"><label>3.</label><p id="p0425">Regions reported an incremental increase in uptake of regional LDCT in the intervention arm which was not reported in the control arm</p></list-item></list></td><td colspan="1" rowspan="1">None</td></tr><tr><td colspan="1" rowspan="1">Dharod et&#160;al.<xref rid="bib35" ref-type="bibr"><sup>35</sup></xref></td><td colspan="1" rowspan="1">2019</td><td colspan="1" rowspan="1">Nonrandomized study</td><td colspan="1" rowspan="1">North Carolina. United States</td><td colspan="1" rowspan="1">Academic health system&#8211;hospitals and community clinics</td><td colspan="1" rowspan="1">To assess the feasibility of targeted electronic messaging through a patient portal to increase LCS uptake</td><td colspan="1" rowspan="1">Patients were selected on the basis of age and smoking history by means of EHR. Electronic messages through the portal. Messages included a link to a screening eligibility assessment and a decision aid. Eligible patients underwent SDM and could proceed with LDCT</td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0100"><list-item id="o0280"><label>1.</label><p id="p0430">Number of patients who read the invitation</p></list-item><list-item id="o0285"><label>2.</label><p id="p0435">Number of patients who visit the interactive website</p></list-item><list-item id="o0290"><label>3.</label><p id="p0440">The number of patients who complete the interactive website. The proportion of eligible screening patients</p></list-item><list-item id="o0295"><label>4.</label><p id="p0445">The proportion of patients who were eligible for LCS</p></list-item><list-item id="o0300"><label>5.</label><p id="p0450">The proportion of patients who completed LCS</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0105"><list-item id="o0305"><label>1.</label><p id="p0455">1000 invites sent by means of patient portals</p></list-item><list-item id="o0310"><label>2.</label><p id="p0460">86% read the invitation</p></list-item><list-item id="o0315"><label>3.</label><p id="p0465">40% visited the interactive website</p></list-item><list-item id="o0320"><label>4.</label><p id="p0470">35% of patients completed the interactive component</p></list-item><list-item id="o0325"><label>5.</label><p id="p0475">99/1000 were identified as screening eligible by the website</p></list-item><list-item id="o0330"><label>6.</label><p id="p0480">22/1000 patients completed LDCT</p></list-item></list></td><td colspan="1" rowspan="1">None</td></tr><tr><td colspan="1" rowspan="1">Veronesi et&#160;al.<xref rid="bib66" ref-type="bibr"><sup>66</sup></xref></td><td colspan="1" rowspan="1">2017</td><td colspan="1" rowspan="1">Nonrandomized study</td><td colspan="1" rowspan="1">Italy</td><td colspan="1" rowspan="1">40 km radius of the regional hospital</td><td colspan="1" rowspan="1">To assess the feasibility of direct home telephone calling to identify eligible patients and to promote the uptake of lung cancer screening</td><td colspan="1" rowspan="1">1000 families were contacted by phone and participated in an eligibility questionnaire. Eligible individuals willing to undergo LDCT scheduled for a free lung cancer screening</td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0110"><list-item id="o0335"><label>1.</label><p id="p0485">The proportion of patients eligible from 1000 families</p></list-item><list-item id="o0340"><label>2.</label><p id="p0490">The proportion of patients who underwent LDCT after a telephone call</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0115"><list-item id="o0345"><label>1.</label><p id="p0495">44 individuals were eligible but 13 agreed to participate in LDCT</p></list-item><list-item id="o0350"><label>2.</label><p id="p0500">12 underwent LDCT (1.2%).</p></list-item></list></td><td colspan="1" rowspan="1">Those who scheduled an LDCT appointment also consented to a smoking cessation interview</td></tr><tr><td colspan="1" rowspan="1">Federman et&#160;al.<xref rid="bib36" ref-type="bibr"><sup>36</sup></xref></td><td colspan="1" rowspan="1">2014</td><td colspan="1" rowspan="1">Retrospective cohort study</td><td colspan="1" rowspan="1">Connecticut, United States</td><td colspan="1" rowspan="1">Veteran Affairs Healthcare system</td><td colspan="1" rowspan="1">To assess the effectiveness of an EHR clinical reminder to increase the uptake of LCS</td><td colspan="1" rowspan="1">Eligible patients identified by means of EHR. Clinical reminders are sent to healthcare providers to conduct eligibility assessments and recommend LDCT screening to the patient</td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0120"><list-item id="o0355"><label>1.</label><p id="p0505">Percentage of completed reminders</p></list-item><list-item id="o0360"><label>2.</label><p id="p0510">Percentage of eligible patients</p></list-item><list-item id="o0365"><label>3.</label><p id="p0515">Percentage uptake of LDCT</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0125"><list-item id="o0370"><label>1.</label><p id="p0520">64.9% of clinical reminders were completed and of those, 39.9% met the LCS criteria</p></list-item><list-item id="o0375"><label>2.</label><p id="p0525">Of the eligible patients, 59.7% agreed to participate, and 76.4% of those completed LDCT screening</p></list-item></list></td><td colspan="1" rowspan="1">None</td></tr><tr><td colspan="1" rowspan="1">Mazzone et&#160;al.<xref rid="bib37" ref-type="bibr"><sup>37</sup></xref></td><td colspan="1" rowspan="1">2017</td><td colspan="1" rowspan="1">Pre and posttest study</td><td colspan="1" rowspan="1">Ohio, United States</td><td colspan="1" rowspan="1">Healthcare Clinic</td><td colspan="1" rowspan="1">To assess the impact of a centralized counseling system consisting of SDM, educational videos, and personalized risk assessment on knowledge and uptake of lung cancer screening</td><td colspan="1" rowspan="1">Patients are referred to the program by their healthcare providers. On referral, patients booked for SDM visits, risk assessment, and LDCT if eligible. Study participants completed knowledge questionnaires before and after the visit, and later after 1 mo</td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0130"><list-item id="o0380"><label>1.</label><p id="p0530">Knowledge improvement scores</p></list-item><list-item id="o0385"><label>2.</label><p id="p0535">Percentage uptake of LDCT</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0135"><list-item id="o0390"><label>1.</label><p id="p0540">Knowledge scores improved after visit <italic toggle="yes">p</italic>&#160;= 0.03 to <italic toggle="yes">p</italic> &lt;.0001</p></list-item><list-item id="o0395"><label>2.</label><p id="p0545">95% of patients proceeded with LDCT</p></list-item></list></td><td colspan="1" rowspan="1">None</td></tr><tr><td colspan="1" rowspan="1">Wang et&#160;al.<xref rid="bib38" ref-type="bibr"><sup>38</sup></xref></td><td colspan="1" rowspan="1">2020</td><td colspan="1" rowspan="1">Retrospective data analysis</td><td colspan="1" rowspan="1">Massachusetts, United States</td><td colspan="1" rowspan="1">Academic medical center associated with a community health center</td><td colspan="1" rowspan="1">To assess the feasibility of integrating tobacco cessation and LCS referrals into a screening mammography program</td><td colspan="1" rowspan="1">All patients participating in screening mammography were asked to complete an intake questionnaire containing smoking history and interest in tobacco cessation programs questionnaire was available in multiple languages and interpreters were also present. Pack-years were calculated by program staff and referrals to LCS were made as needed</td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0140"><list-item id="o0400"><label>1.</label><p id="p0550">Smoking status of screening mammography patients</p></list-item><list-item id="o0405"><label>2.</label><p id="p0555">The proportion of current smokers who requested a referral to a smoking cessation program</p></list-item><list-item id="o0410"><label>3.</label><p id="p0560">The proportion of patients eligible for LCS on the basis of pack-year smoking history</p></list-item><list-item id="o0415"><label>4.</label><p id="p0565">The proportion of smokers newly identified for LCS through the program</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0145"><list-item id="o0420"><label>1.</label><p id="p0570">10.5% self-reported as current cigarette smokers, 29.1% self-reported as former smokers</p></list-item><list-item id="o0425"><label>2.</label><p id="p0575">Among current smokers, 26.4% requested a referral to the tobacco cessation program</p></list-item><list-item id="o0430"><label>3.</label><p id="p0580">9.3% (n&#160;= 70) of ever-smokers were eligible for LCS on the basis of pack-year smoking history</p></list-item><list-item id="o0435"><label>4.</label><p id="p0585">2% of the study population newly identified as eligible for lung cancer screening</p></list-item></list></td><td colspan="1" rowspan="1">Tobacco cessation services</td></tr><tr><td colspan="1" rowspan="1">Ruparel et&#160;al.<xref rid="bib58" ref-type="bibr"><sup>58</sup></xref></td><td colspan="1" rowspan="1">2019</td><td colspan="1" rowspan="1">Randomized controlled trial</td><td colspan="1" rowspan="1">United Kingdom</td><td colspan="1" rowspan="1">Out patient clinics at a London Hospital</td><td colspan="1" rowspan="1">To assess the impact of an informational film on the decision to participate in lung cancer screening</td><td colspan="1" rowspan="1">Primary care records are used to identify ever-smokers between 60&#8211;75 years of age and invite them to an LHC. Attendees to LHC were randomly assigned to each arm of the study. The control group received an informational booklet only. Thentervention group received an informational film and an informational booklet</td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0150"><list-item id="o0440"><label>1.</label><p id="p0590">Percentage uptake of LDCT across control and ntervention groups</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0155"><list-item id="o0445"><label>1.</label><p id="p0595">LDCT completion rates across intervention and control groups were 76.7% and 78.9% respectively</p></list-item></list></td><td colspan="1" rowspan="1">Not described</td></tr><tr><td colspan="1" rowspan="1">Quaife et&#160;al.<xref rid="bib62" ref-type="bibr"><sup>62</sup></xref></td><td colspan="1" rowspan="1">2020</td><td colspan="1" rowspan="1">Randomized controlled trial</td><td colspan="1" rowspan="1">United Kingdom</td><td colspan="1" rowspan="1">Out patient clinics at a London Hospital</td><td colspan="1" rowspan="1">To assess the impact of a targeted, stepped, and low-burden invitation intervention on the uptake of LDCT</td><td colspan="1" rowspan="1">Primary care practices serving communities with lower socioeconomic status as measured by the IMD-identified eligible patients through EHR i.e., ever-smokers between 60&#8211;75 years of age. Patients received stepped invitations to participate in LHC through primary care endorsement, prenotification, leaflets, reminders, and prescheduled appointments. The intervention arm included a modified leaflet</td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0160"><list-item id="o0450"><label>1.</label><p id="p0600">IMD ranking of invitees</p></list-item><list-item id="o0455"><label>2.</label><p id="p0605">Percentage of attendance of the LHC appointment</p></list-item><list-item id="o0460"><label>3.</label><p id="p0610">The proportion of attendees eligible for LDCT</p></list-item><list-item id="o0465"><label>4.</label><p id="p0615">The difference in attendance levels between intervention and control groups</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0165"><list-item id="o0470"><label>1.</label><p id="p0620">96.2% of invitees ranked as most deprived (60.9%) or second-most deprived (35.3%) on the basis of IMD</p></list-item><list-item id="o0475"><label>2.</label><p id="p0625">52.6% of invitees attended LHC appointment</p></list-item><list-item id="o0480"><label>3.</label><p id="p0630">84% of attendees eligible for LDCT</p></list-item><list-item id="o0485"><label>4.</label><p id="p0635">No difference in LHC attendance between intervention (52.3%) and control (52.9%) groups</p></list-item></list></td><td colspan="1" rowspan="1">Attendees could opt-into a smoking cessation program</td></tr><tr><td colspan="1" rowspan="1">Percac-Lima et&#160;al.<xref rid="bib39" ref-type="bibr"><sup>39</sup></xref></td><td colspan="1" rowspan="1">2018</td><td colspan="1" rowspan="1">Randomized controlled trial</td><td colspan="1" rowspan="1">Massachusetts, United States</td><td colspan="1" rowspan="1">Five community health centers affiliated with an academic primary care network</td><td colspan="1" rowspan="1">To evaluate the impact of a patient navigation program to increase LCS uptake in current smokers</td><td colspan="1" rowspan="1">EHR is used to identify current smokers who were<break/>55&#8211;77 years old. The intervention group received invitation materials by means of mail and a call from the patient navigator about LCS. The control group received the usual care</td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0170"><list-item id="o0490"><label>1.</label><p id="p0640">The proportion of patients eligible for LCS in the intervention group</p></list-item><list-item id="o0495"><label>2.</label><p id="p0645">The proportion of patients across intervention and control groups that had LDCT</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0175"><list-item id="o0500"><label>1.</label><p id="p0650">Of 259 patients in the intervention group, 135 were eligible.</p></list-item><list-item id="o0505"><label>2.</label><p id="p0655">Percentage uptake of LDCT was 23.5% in the intervention and 8.6% in the control group</p></list-item></list></td><td colspan="1" rowspan="1">None</td></tr><tr><td colspan="1" rowspan="1">Bartlett et&#160;al.<xref rid="bib60" ref-type="bibr"><sup>60</sup></xref></td><td colspan="1" rowspan="1">2020</td><td colspan="1" rowspan="1">Nonrandomized study</td><td colspan="1" rowspan="1">United Kingdom</td><td colspan="1" rowspan="1">Mobile scanners and a hospital in West London</td><td colspan="1" rowspan="1">To compare participant uptake between a mobile and hospital-based CT scanner</td><td colspan="1" rowspan="1">Letters of invitation were sent to age-eligible smokers identified through primary care practices. Individuals who booked an LHC appointment were assessed for lung cancer risk using the PLCO score and LLP. Individuals with PLCO score greater than or equal to 1.51% or LLP greater than or equal to 2% were offered immediate LDCT screening at the hospital site or mobile scanner</td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0180"><list-item id="o0510"><label>1.</label><p id="p0660">Attendance rates and percentage uptake of LCS at each site</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0185"><list-item id="o0515"><label>1.</label><p id="p0665">At the hospital site, 20.4% attended while at the mobile site, 21.7% attended.</p></list-item><list-item id="o0520"><label>2.</label><p id="p0670">Of the 1159 patients who were eligible for LDCT, 1145 underwent baseline LDCT scanning (98.8%)</p></list-item></list></td><td colspan="1" rowspan="1">Not described</td></tr><tr><td colspan="1" rowspan="1">Reuland et&#160;al.<xref rid="bib40" ref-type="bibr"><sup>40</sup></xref></td><td colspan="1" rowspan="1">2018</td><td colspan="1" rowspan="1">Pre and posttest study</td><td colspan="1" rowspan="1">North Carolina, United States</td><td colspan="1" rowspan="1">Academic primary care practice</td><td colspan="1" rowspan="1">To assess the effectiveness of a video-based decision aid to promote decision-making for LCS within a primary care setting</td><td colspan="1" rowspan="1">Patients (on the basis of age and smoking history) identified by means of EHR and sent recruitment package by means of post. Eligibility for LCS is determined by means of telephone and patient scheduled for an in-person visit. Study participants viewed the video at the clinic and completed a baseline knowledge survey, follow-up survey, and another survey at 3 mo</td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0190"><list-item id="o0525"><label>1.</label><p id="p0675">Screening-related knowledge score pre and postintervention</p></list-item><list-item id="o0530"><label>2.</label><p id="p0680">Screening behavior measures, assessed by means of chart review, including LDCT ordering, and LDCT completion within 3 mo</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0195"><list-item id="o0535"><label>1.</label><p id="p0685">Of the 716 recruitment packages mailed and 378 patients reached by means of telephone, 80 patients were found to be eligible and ultimately 50 participated.</p></list-item><list-item id="o0540"><label>2.</label><p id="p0690">Knowledge increased from pre- to postdecision aid viewing (mean&#160;= 2.6 vs. 5.5)</p></list-item><list-item id="o0545"><label>3.</label><p id="p0695">13/50 participants had LDCT ordered</p></list-item><list-item id="o0550"><label>4.</label><p id="p0700">10/50 participants completed LDCT</p></list-item></list></td><td colspan="1" rowspan="1">None</td></tr><tr><td colspan="1" rowspan="1">Crosbie et&#160;al.</td><td colspan="1" rowspan="1">2019</td><td colspan="1" rowspan="1">Nonrandomized study</td><td colspan="1" rowspan="1">United Kingdom</td><td colspan="1" rowspan="1">Retail locations in socioeconomically deprived neighborhoods on the basis of the Index of Multiple</td><td colspan="1" rowspan="1">To report on the results of two rounds of community-based mobile LCS in socioeconomically deprived neighborhoods</td><td colspan="1" rowspan="1">Letters of invitation were sent to age-eligible smokers identified through primary care practices. Individuals who booked an LHC appointment were assessed for lung cancer risk using the PLCO score. Individuals with PLCO score greater than or equal to 1.51% were offered immediate LDCT screening through a mobile scanner (T0) and reinvited to screen after 12 mo (T1)</td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0200"><list-item id="o0555"><label>1.</label><p id="p0705">Screening adherence i.e. percentage of attendees who completed T0 and T1 scans</p></list-item><list-item id="o0560"><label>2.</label><p id="p0710">Incidence and stage of lung cancer in the scanned population</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0205"><list-item id="o0565"><label>1.</label><p id="p0715">90% of eligible attendees completed T0 and T1 scans (1194/1323)</p></list-item><list-item id="o0570"><label>2.</label><p id="p0720">1.6% of the scanned population had lung cancer detected and 79% of those lung cancers were stage 1</p></list-item></list></td><td colspan="1" rowspan="1">Smoking cessation advice offered during LHC&#8211;unclear if ongoing smoking cessation services were provided at T1</td></tr><tr><td colspan="1" rowspan="1">Lam et&#160;al.<xref rid="bib41" ref-type="bibr"><sup>41</sup></xref></td><td colspan="1" rowspan="1">2021</td><td colspan="1" rowspan="1">Prospective study</td><td colspan="1" rowspan="1">California, United States</td><td colspan="1" rowspan="1">Genomics Institute and Oncology Department of Hospital</td><td colspan="1" rowspan="1">To assess the utilization of a personalized gene-based risk test and its effect on attendance for LCS uptake and adherence in a small, community-based pilot</td><td colspan="1" rowspan="1">Patients were recruited by means of advertisements and physician referrals. Participants completed a questionnaire and did a cheek swap. LDCT offered to eligible patients</td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0210"><list-item id="o0575"><label>1.</label><p id="p0725">Adherence and attendance rates of LDCT screening &#8764; categorized as "Timely" and "Late". Timely was defined as scheduling attendance within 4 wks after a positive scan. Late was defined as those who attended more than 4 wks after their scheduled attendance for a positive</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0215"><list-item id="o0585"><label>1.</label><p id="p0735">98% of enrolled participants underwent a baseline CT scan</p></list-item><list-item id="o0590"><label>2.</label><p id="p0740">The rate of &#8220;timely&#8221; adherence was 43% &#8220;Overall&#8221; adherence (including timely and late) was 63%. No adherence was 37%</p></list-item></list></td><td colspan="1" rowspan="1">Smoking cessation counseling offered to current smokers</td></tr><tr><td colspan="1" rowspan="1">Volk et&#160;al.<xref rid="bib42" ref-type="bibr"><sup>42</sup></xref></td><td colspan="1" rowspan="1">2020</td><td colspan="1" rowspan="1">Randomized controlled trial</td><td colspan="1" rowspan="1">Texas, United States</td><td colspan="1" rowspan="1">13 Texas State tobacco quitlines</td><td colspan="1" rowspan="1">To determine the effect of a video-based PDA about LCS on decision-making, knowledge, and screening outcomes</td><td colspan="1" rowspan="1">Quitline call centers sent recruitment packages to clients. Clients received either the video or a brochure as standard educational materials (EDU). Follow-up questionnaires completed by mail/ phone at 1 wk, 3 mo and 6 months</td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0220"><list-item id="o0595"><label>1.</label><p id="p0745">Knowledge of LCS at 1-wk, 3-month, and 6-month intervals</p></list-item><list-item id="o0600"><label>2.</label><p id="p0750">Percentage LDCT scheduled across intervention and control groups</p></list-item><list-item id="o0605"><label>3.</label><p id="p0755">Percentage uptake LDCT</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0225"><list-item id="o0610"><label>1.</label><p id="p0760">LCS knowledge is higher in the PDA group. Scores at 1 wk 57.5% 3 months 44.4% and 6 months 49.9% compared with the 1-wk assessment.</p></list-item><list-item id="o0615"><label>2.</label><p id="p0765">29.5% of PDA patients and 37.4% of EDU patients scheduled LDCT by 6 months</p></list-item><list-item id="o0620"><label>3.</label><p id="p0770">85.1% of the PDA group and 80% of the EDU group who scheduled LDCT got screened within 6 months</p></list-item></list></td><td colspan="1" rowspan="1">The intervention was centered around a smoking cessation service</td></tr><tr><td colspan="1" rowspan="1">Tanner et&#160;al.<xref rid="bib43" ref-type="bibr"><sup>43</sup></xref></td><td colspan="1" rowspan="1">2020</td><td colspan="1" rowspan="1">Nonrandomized study</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">Eight Veteran Affairs hospitals</td><td colspan="1" rowspan="1">To measure adherence rates in LCS of the Veterans Affairs LCS demonstration project</td><td colspan="1" rowspan="1">Clinical sites required at minimum: leadership support, clinical champions, onsite CT scanner, radiologist, multidisciplinary lung cancer program, and tobacco cessation program. Eligible patients identified by means of EHR. The program coordinator confirmed eligibility and conducted SDM in person. Patients booked for LDCT if eligible. Follow-up scans booked by phone</td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0230"><list-item id="o0625"><label>1.</label><p id="p0775">Percentage adherence to annual LDCT after baseline screening (follow-up scan within 15 months is considered adherent)</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0235"><list-item id="o0630"><label>1.</label><p id="p0780">Adherence from baseline scan to T1 was 82.2% and from T1 to T2, adherence was 65.2%</p></list-item></list></td><td colspan="1" rowspan="1">Smoking cessation is available at the clinical site</td></tr><tr><td colspan="1" rowspan="1">Kinsinger et&#160;al.<xref rid="bib44" ref-type="bibr"><sup>44</sup></xref></td><td colspan="1" rowspan="1">2017</td><td colspan="1" rowspan="1">Nonrandomized study</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">Eight Veteran Affairs hospitals</td><td colspan="1" rowspan="1">To assess the feasibility of a multipronged intervention on the uptake of LCS</td><td colspan="1" rowspan="1">Clinical sites required at minimum: leadership support, clinical champions, onsite CT scanner, radiologist, multidisciplinary lung cancer program, and tobacco cessation program. Eligible patients identified by means of EHR. The program coordinator confirmed eligibility and conducted SDM in person. Patients booked for LDCT if eligible</td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0240"><list-item id="o0635"><label>1.</label><p id="p0785">Percentage of eligible patients</p></list-item><list-item id="o0640"><label>2.</label><p id="p0790">Percentage uptake LDCT</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0245"><list-item id="o0645"><label>1.</label><p id="p0795">84.3% of identified patients eligible for screening</p></list-item><list-item id="o0650"><label>2.</label><p id="p0800">57.5% of eligible patients agreed to be screened and of those who agreed, 85.9% completed the first LDCT</p></list-item></list></td><td colspan="1" rowspan="1">Smoking cessation is available at the clinical site</td></tr><tr><td colspan="1" rowspan="1">Monu et&#160;al.<xref rid="bib45" ref-type="bibr"><sup>45</sup></xref></td><td colspan="1" rowspan="1">2022</td><td colspan="1" rowspan="1">Randomized study</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">Not applicable</td><td colspan="1" rowspan="1">To determine the impact of different advertisement images on the self-reported likelihood of undergoing lung cancer screening</td><td colspan="1" rowspan="1">Screen-eligible participants were recruited by means of a crowdsourcing recruitment tool. Participants were randomized to view combinations of construal level (intervention) and regulatory focus (control) images. After viewing the images, participants were asked about their likelihood to undergo LCS</td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0250"><list-item id="o0655"><label>1.</label><p id="p0805">Percentage of participants that completed the survey</p></list-item><list-item id="o0660"><label>2.</label><p id="p0810">Percentage likelihood to screen for lung cancer in each group</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0255"><list-item id="o0665"><label>1.</label><p id="p0815">79% of participants completed the survey</p></list-item><list-item id="o0670"><label>2.</label><p id="p0820">Images with high construal and promotion focus led to a greater self-reported likelihood of screening among participants at high risk for lung cancer (60% versus 30% in control)</p></list-item></list></td><td colspan="1" rowspan="1">None</td></tr><tr><td colspan="1" rowspan="1">Williams et&#160;al.<xref rid="bib46" ref-type="bibr"><sup>46</sup></xref></td><td colspan="1" rowspan="1">2021</td><td colspan="1" rowspan="1">Pre and posttest study</td><td colspan="1" rowspan="1">Georgia, United States</td><td colspan="1" rowspan="1">12 community sites &#8764; 8 African American churches, three federally qualified health clinics, and one community recreation center</td><td colspan="1" rowspan="1">To alter the participants' knowledge, attitudes, and beliefs about lung cancer risk factors and to connect screening eligible participants to free LDCT screening services and tobacco cessation services</td><td colspan="1" rowspan="1">Weekly education sessions are held at community sites and are led by community health workers. Educational and informational tools (flyers, posters, checklists) are provided to community members. Participants completed the questionnaire. Follow-up occurred by phone</td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0260"><list-item id="o0675"><label>1.</label><p id="p0825">Participant knowledge regarding LCS, cues to action, and intent to undergo LCS</p></list-item><list-item id="o0680"><label>2.</label><p id="p0830">Percentage uptake LDCT screening</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0265"><list-item id="o0685"><label>1.</label><p id="p0835">Knowledge regarding LCS increased: 25.3% (pretest) versus 79.8% (posttest)</p></list-item><list-item id="o0690"><label>2.</label><p id="p0840">3 months postintervention, 38% of eligible participants underwent LDCT</p></list-item></list></td><td colspan="1" rowspan="1">Tobacco cessation services available to current smokers</td></tr><tr><td colspan="1" rowspan="1">Fabbrini et&#160;al.<xref rid="bib47" ref-type="bibr"><sup>47</sup></xref></td><td colspan="1" rowspan="1">2018</td><td colspan="1" rowspan="1">Randomized controlled study</td><td colspan="1" rowspan="1">Minneapolis, United States</td><td colspan="1" rowspan="1">Veteran Affairs Health care system</td><td colspan="1" rowspan="1">To measure the impact of targeted invitation strategies on the uptake of lung cancer screening</td><td colspan="1" rowspan="1">Eligible patients identified by means of EHR. The intervention group received invitation materials by post with a follow-up one wk later. The care coordinator conducted risk assessments and booked patients for LCS if eligible. The control group received the usual care</td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0270"><list-item id="o0695"><label>1.</label><p id="p0845">Percentage of patients for LCS on the basis of EHR</p></list-item><list-item id="o0700"><label>2.</label><p id="p0850">Percentage uptake LDCT</p></list-item><list-item id="o0705"><label>3.</label><p id="p0855">Percentage uptake of LDCT across intervention and control groups</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0275"><list-item id="o0710"><label>1.</label><p id="p0860">66% of patients identified by means of EHR were eligible for LDCT</p></list-item><list-item id="o0715"><label>2.</label><p id="p0865">19% of the study population completed LDCT</p></list-item><list-item id="o0720"><label>3.</label><p id="p0870">Uptake of LDCT 22% in the intervention group (received invitation materials and care navigation) underwent LDCT versus 9% in the control group</p></list-item></list></td><td colspan="1" rowspan="1">Tobacco cessation program</td></tr><tr><td colspan="1" rowspan="1">Han et&#160;al.<xref rid="bib48" ref-type="bibr"><sup>48</sup></xref></td><td colspan="1" rowspan="1">2019</td><td colspan="1" rowspan="1">Pre and posttest study</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">LDCT screening program in a hospital setting</td><td colspan="1" rowspan="1">To evaluate the effects of personalized cancer risk information on patients' perception of risk and interest in lung cancer screening</td><td colspan="1" rowspan="1">Eligible patients referred from community primary care practices to the LCS program. SDM consultations are conducted by pulmonary physicians using personalized decision aid. Pre and postintervention surveys were conducted, and participants who had LDCT also did a qualitative interview</td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0280"><list-item id="o0725"><label>1.</label><p id="p0875">Interest in LCS pre and postintervention</p></list-item><list-item id="o0730"><label>2.</label><p id="p0880">Percentage uptake of LDCT</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0285"><list-item id="o0735"><label>1.</label><p id="p0885">Interest in LCS increased from 4.37 on a five-point scale to 4.70 postvisit</p></list-item><list-item id="o0740"><label>2.</label><p id="p0890">100% eligible patients scheduled and completed LDCT</p></list-item></list></td><td colspan="1" rowspan="1">Participants were asked about their interest in smoking cessation but no services were described</td></tr><tr><td colspan="1" rowspan="1">Azubuike et&#160;al.<xref rid="bib49" ref-type="bibr"><sup>49</sup></xref></td><td colspan="1" rowspan="1">2020</td><td colspan="1" rowspan="1">Pre and posttest study</td><td colspan="1" rowspan="1">Michigan, United States</td><td colspan="1" rowspan="1">Family Medicine clinic</td><td colspan="1" rowspan="1">To increase provider compliance with USPSTF LCS guidelines using a multiprong intervention</td><td colspan="1" rowspan="1">1-hour educational session conducted for staff. Flyers were placed in the clinic to remind providers to order LDCT tests. Pre and posteducational session tests were administered.<break/>EHR is used to identify eligible patients and is contacted by the office manager using a phone script to complete the assessment form. Providers followed up on forms and ordered LDCT for those interested</td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0290"><list-item id="o0745"><label>1.</label><p id="p0895">Population eligible for LDCT</p></list-item><list-item id="o0750"><label>2.</label><p id="p0900">Percentage of LDCT ordered</p></list-item><list-item id="o0755"><label>3.</label><p id="p0905">LDCT uptake difference pre vs. postintervention</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0295"><list-item id="o0760"><label>1.</label><p id="p0910">27 patients eligible for LDCT</p></list-item><list-item id="o0765"><label>2.</label><p id="p0915">8/27 patients referred to LDCT</p></list-item><list-item id="o0770"><label>3.</label><p id="p0920">19/27 eligible patients declined LDCT</p></list-item><list-item id="o0775"><label>4.</label><p id="p0925">Preintervention, 0 LDCT orders vs. 8 LDCT orders postintervention</p></list-item></list></td><td colspan="1" rowspan="1">None</td></tr><tr><td colspan="1" rowspan="1">McDonnell et&#160;al.<xref rid="bib50" ref-type="bibr"><sup>50</sup></xref></td><td colspan="1" rowspan="1">2018</td><td colspan="1" rowspan="1">Prospective-Mixed methods</td><td colspan="1" rowspan="1">Southeast United States</td><td colspan="1" rowspan="1">The academic medical center serves low-income individuals</td><td colspan="1" rowspan="1">To assess the feasibility of a clinic-based decision aid to promote discussion and referral to LDCT</td><td colspan="1" rowspan="1">Eligible patients identified by means of EHR. Patients were randomly selected to receive mailed invitations and phone calls. Providers received educational materials. The patient booked an appointment with the provider and together completed 8-page decision aid designed at a grade 5 reading level. Patients and providers participate in the survey. Patients also completed an exit interview</td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0300"><list-item id="o0780"><label>1.</label><p id="p0930">Acceptability of DA</p></list-item><list-item id="o0785"><label>2.</label><p id="p0935">Percentage of patients wanting to receive LDCT</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0305"><list-item id="o0790"><label>1.</label><p id="p0940">Participants felt DA was easy to read (100%), helpful for making decisions (100%), for discussing personal values (95%), the appropriate time required to read and use the DA (100%), and 95% reported increased satisfaction with the visit.</p></list-item><list-item id="o0795"><label>2.</label><p id="p0945">80% of eligible patients expressed a desire for LDCT DA</p></list-item></list></td><td colspan="1" rowspan="1">None</td></tr><tr><td colspan="1" rowspan="1">Spalluto et&#160;al.<xref rid="bib51" ref-type="bibr"><sup>51</sup></xref></td><td colspan="1" rowspan="1">2020</td><td colspan="1" rowspan="1">Retrospective&#8211;mixed methods</td><td colspan="1" rowspan="1">Midsouth United States</td><td colspan="1" rowspan="1">Lung screening program at Academic medical center</td><td colspan="1" rowspan="1">To assess the impact of adding a dedicated program coordinator on LCS adherence rates</td><td colspan="1" rowspan="1">Retrospective data collection to identify patients that underwent LDCT. Participants completed a cross-sectional survey by means of telephone. Program coordinator responsibilities included: SDM, smoking cessation, and tracking of program participants</td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0310"><list-item id="o0800"><label>1.</label><p id="p0950">Percentage adherence to annual follow-up LDCT</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0315"><list-item id="o0805"><label>1.</label><p id="p0955">30.4% adherence before the program coordinator vs. 69.6% after hiring a program coordinator</p></list-item></list></td><td colspan="1" rowspan="1">Tobacco treatment counseling</td></tr><tr><td colspan="1" rowspan="1">Raz et&#160;al.<xref rid="bib52" ref-type="bibr"><sup>52</sup></xref></td><td colspan="1" rowspan="1">2021</td><td colspan="1" rowspan="1">Randomized controlled trial</td><td colspan="1" rowspan="1">California</td><td colspan="1" rowspan="1">Integrated health care system</td><td colspan="1" rowspan="1">To determine the effects of an educational LCS video on utilizing chest CT and smoking habits for individuals who are participating in in-person, telephone, or online smoking cessation services</td><td colspan="1" rowspan="1">E-mail invitation (followed up by postcard and phone call as needed) sent to existing patients of a smoking cessation program. The E-mail contained a link to 30 min educational video describing lung cancer risk and LCS. The survey is to be completed after watching the educational video for the intervention group. The control group did not receive invite or video</td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0320"><list-item id="o0810"><label>1.</label><p id="p0960">Percentage of participants who completed the survey and education video</p></list-item><list-item id="o0815"><label>2.</label><p id="p0965">Percentage uptake of chest CT across control and intervention group</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0325"><list-item id="o0820"><label>1.</label><p id="p0970">14% completed watching the video and 13% completed the survey</p></list-item><list-item id="o0825"><label>2.</label><p id="p0975">Chest CT uptake was 8.5% and 8.6% for the intervention and control groups respectively</p></list-item></list></td><td colspan="1" rowspan="1">Smoking cessation counseling (group or telephone)</td></tr><tr><td colspan="1" rowspan="1">Watson et&#160;al.</td><td colspan="1" rowspan="1">2020</td><td colspan="1" rowspan="1">Pre and posttest study</td><td colspan="1" rowspan="1">Texas, United States</td><td colspan="1" rowspan="1">LCS program in the hospital setting</td><td colspan="1" rowspan="1">To determine the impact of ONN on uptake and</td><td colspan="1" rowspan="1">ONN provided education and resources to staff. Identified eligible patients from EHR, confirmed eligibility with the primary care provider, and contacted patients to book assessments. ONN identified and removed barriers to access, such as costs. Eligible patients underwent LDCT and the time between referrals and reporting was tracked</td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0330"><list-item id="o0830"><label>1.</label><p id="p0980">Increase uptake of LDCT</p></list-item><list-item id="o0835"><label>2.</label><p id="p0985">Decrease time from primary care provider referral to LDCT, and from LDCT to reporting results back to provider and patient</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0335"><list-item id="o0840"><label>1.</label><p id="p0990">Hospital LDCT increased from 38% to 65%</p></list-item><list-item id="o0845"><label>2.</label><p id="p0995">No decrease in time from referral to LDCT screening. Reporting back of results to provider and then patient improved by 2,6 ds and 1.5 d respectively</p></list-item></list></td><td colspan="1" rowspan="1">Tobacco cessation referrals to quitlines and other resources provided to patients</td></tr><tr><td colspan="1" rowspan="1">Ghimire et&#160;al.<xref rid="bib63" ref-type="bibr"><sup>63</sup></xref></td><td colspan="1" rowspan="1">2019</td><td colspan="1" rowspan="1">Nonrandomized study</td><td colspan="1" rowspan="1">United Kingdom</td><td colspan="1" rowspan="1">Community health hub in the area of economic deprivation</td><td colspan="1" rowspan="1">To assess the impact of targeted health promotion and community-based lung health checks on the uptake of LDCT in deprived neighborhoods as measured by the IMD</td><td colspan="1" rowspan="1">Targeted health campaign conducted promoting lung health. Letters of invitation were sent to age-eligible smokers identified through primary care practices. Individuals who booked an LHC appointment were assessed f using the Liverpool Lung Project risk calculator to determine the risk of lung cancer over the next 5 years. Those with 5% or higher risk were referred to LDCT</td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0340"><list-item id="o0850"><label>1.</label><p id="p1000">Attendance rates</p></list-item><list-item id="o0855"><label>2.</label><p id="p1005">Percentage uptake LDCT</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0345"><list-item id="o0860"><label>1.</label><p id="p1010">40% of invitees attended the lung health check</p></list-item><list-item id="o0865"><label>2.</label><p id="p1015">Of those eligible for LCS, 85% had LDCT</p></list-item></list></td><td colspan="1" rowspan="1">Smoking cessation clinic referrals</td></tr><tr><td colspan="1" rowspan="1">Grover et&#160;al.<xref rid="bib59" ref-type="bibr"><sup>59</sup></xref></td><td colspan="1" rowspan="1">2020</td><td colspan="1" rowspan="1">Nonrandomized study</td><td colspan="1" rowspan="1">United Kingdom</td><td colspan="1" rowspan="1">Primary care practice in areas of economic deprivation as measured by IMD rank</td><td colspan="1" rowspan="1">To assess the impact of targeting patients from annual COPD review to participate in LDCT</td><td colspan="1" rowspan="1">Patients identified from chart review conducted at annual COPD check. Eligible patients offered LCS</td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0350"><list-item id="o0870"><label>1.</label><p id="p1020">Patient socioeconomic status</p></list-item><list-item id="o0875"><label>2.</label><p id="p1025">Number of LDCT scans conducted</p></list-item><list-item id="o0880"><label>3.</label><p id="p1030">Prevalence of lung cancer in the study population</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0355"><list-item id="o0885"><label>1.</label><p id="p1035">79.3% of attendees were from the most deprived quintiles (IMD ranking)</p></list-item><list-item id="o0890"><label>2.</label><p id="p1040">925 attendees underwent LDCT</p></list-item><list-item id="o0895"><label>3.</label><p id="p1045">Lung cancer prevalence was 2% (n&#160;= 19/925)</p></list-item></list></td><td colspan="1" rowspan="1">None</td></tr><tr><td colspan="1" rowspan="1">Headrick et&#160;al.<xref rid="bib54" ref-type="bibr"><sup>54</sup></xref></td><td colspan="1" rowspan="1">2020</td><td colspan="1" rowspan="1">Nonrandomized study</td><td colspan="1" rowspan="1">Tennessee, United States</td><td colspan="1" rowspan="1">Rural community settings to target geographically isolated communities</td><td colspan="1" rowspan="1">To assess the feasibility of a mobile LCS program</td><td colspan="1" rowspan="1">Mobile CT scanner buses traveled to rural communities to increase the uptake of LCS. Raised awareness of LDCT though print media, television, and the internet</td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0360"><list-item id="o0900"><label>1.</label><p id="p1050">Number of sites traveled</p></list-item><list-item id="o0905"><label>2.</label><p id="p1055">Number of LDCT scans</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0365"><list-item id="o0910"><label>1.</label><p id="p1060">Traveled to 104 sites during the 1-year duration</p></list-item><list-item id="o0915"><label>2.</label><p id="p1065">548 patients underwent LDCT</p></list-item></list></td><td colspan="1" rowspan="1">None</td></tr><tr><td colspan="1" rowspan="1">Peckham<xref rid="bib55" ref-type="bibr"><sup>55</sup></xref><sup>,</sup><xref rid="tbl2fna" ref-type="table-fn">a</xref></td><td colspan="1" rowspan="1">2016</td><td colspan="1" rowspan="1">Gray literature</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">Hospital</td><td colspan="1" rowspan="1">To describe the role of a nurse practitioner in improving the uptake of LDCT in an LCS program</td><td colspan="1" rowspan="1">Eligible patients referred by physicians or self-referred. Patients are contacted by a nurse practitioner to schedule risk assessment and LDCT. Nurse practitioners managed care pathway</td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0370"><list-item id="o0920"><label>1.</label><p id="p1070">Number of patients that underwent LDCT</p></list-item><list-item id="o0925"><label>2.</label><p id="p1075">Rate of follow-up LDCT scans</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="olist0375"><list-item id="o0930"><label>1.</label><p id="p1080">424 patients screened from 2014&#8211;2016</p></list-item><list-item id="o0935"><label>2.</label><p id="p1085">96% screening follow-up rate</p></list-item></list></td><td colspan="1" rowspan="1">Smoking cessation advice offered during SDM</td></tr></tbody></table><table-wrap-foot><fn><p>COPD, chronic obstructive pulmonary disease; CT, computed tomography; DA, decision aid; DCP, decision counseling program; EHR, electronic health record; EMR, electronic medical record; IMD, index of multiple deprivation; LCS, lung cancer screening; LHC, lung health check; LDCT, low-dose computed tomography; LLP, Liverpool Lung Project; ONN, Oncology Nurse Navigation; PDA, patient decision aid; PLCO, prostate lung colorectal and ovarian; SDM, shared decision making; USPSTF, U.S. Preventive Services Task Force.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl2fna"><label>a</label><p id="ntpara0020">One gray literature article is included.</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="sec3.3"><title>Health Equity Impacts of Interventions Designed to Increase the Uptake of LCS</title><p id="p0105">Priority populations were the focus of the intervention for 22 studies (<xref rid="tbl3" ref-type="table">Table&#160;3</xref>). Of these, nine studies targeted populations living with low-income or in low-income neighborhoods<xref rid="bib39" ref-type="bibr"><sup>39</sup></xref><sup>,</sup><xref rid="bib56" ref-type="bibr">56</xref>, <xref rid="bib57" ref-type="bibr">57</xref>, <xref rid="bib58" ref-type="bibr">58</xref>, <xref rid="bib59" ref-type="bibr">59</xref><sup>,</sup><xref rid="bib61" ref-type="bibr">61</xref>, <xref rid="bib62" ref-type="bibr">62</xref>, <xref rid="bib63" ref-type="bibr">63</xref>, <xref rid="bib64" ref-type="bibr">64</xref>; five targeted geographic areas of high-risk (on the basis of smoking rates and incidence of lung cancer),<xref rid="bib49" ref-type="bibr"><sup>49</sup></xref><sup>,</sup><xref rid="bib53" ref-type="bibr"><sup>53</sup></xref><sup>,</sup><xref rid="bib56" ref-type="bibr"><sup>56</sup></xref><sup>,</sup><xref rid="bib60" ref-type="bibr"><sup>60</sup></xref><sup>,</sup><xref rid="bib65" ref-type="bibr"><sup>65</sup></xref> and an additional two focused on high-risk rural locations.<xref rid="bib34" ref-type="bibr"><sup>34</sup></xref><sup>,</sup><xref rid="bib54" ref-type="bibr"><sup>54</sup></xref> Three studies focused on diverse population groups including ethnic minorities and underserved communities<xref rid="bib32" ref-type="bibr"><sup>32</sup></xref><sup>,</sup><xref rid="bib46" ref-type="bibr"><sup>46</sup></xref><sup>,</sup><xref rid="bib56" ref-type="bibr"><sup>56</sup></xref>; four were designed specifically to improve uptake of LDCT in Veterans<xref rid="bib36" ref-type="bibr"><sup>36</sup></xref><sup>,</sup><xref rid="bib43" ref-type="bibr"><sup>43</sup></xref><sup>,</sup><xref rid="bib44" ref-type="bibr"><sup>44</sup></xref><sup>,</sup><xref rid="bib47" ref-type="bibr"><sup>47</sup></xref>; one targeted uptake in minority women<xref rid="bib38" ref-type="bibr"><sup>38</sup></xref> and one intervention catered only to those receiving Medicare or Medicaid (U.S. public health insurance program).<xref rid="bib50" ref-type="bibr"><sup>50</sup></xref> Of note, no articles described interventions targeting indigenous communities.<table-wrap position="float" id="tbl3" orientation="portrait"><label>Table&#160;3</label><caption><p>Health Equity Assessment of Interventions</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1"><break/>Author&#8217;s Name(s) and Year</th><th colspan="1" rowspan="1">Target Population of Intervention</th><th colspan="1" rowspan="1">Were Priority Populations a Target of the Intervention? (Yes/No)</th><th colspan="1" rowspan="1">Positive Impacts (Intended and/or Unintended)</th><th colspan="1" rowspan="1">Negative Impacts (Intended and/or Unintended)</th><th colspan="1" rowspan="1">Dimensions of Accessibility (Khassanov et&#160;al.)<break/>Affordability Indicates That Direct and Indirect Costs Linked to LDCT Are Taken into Consideration<xref rid="tbl3fna" ref-type="table-fn">a</xref></th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Fagan et&#160;al. (2020)<xref rid="bib31" ref-type="bibr"><sup>31</sup></xref></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0010"><list-item id="u0010"><label>&#8226;</label><p id="p1090">Individuals who meet the 2013 USPSTF guidelines for annual screening i.e.</p></list-item></list>55 and 80 years of age, with at least a 30-pack-year history of smoking, who either currently smoke, or quit less than 15 years ago</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">&#8226; Ability to perceive risk (received SDM and had access to tobacco cessation hotline)<break/>&#8226; Ability to engage (patients were involved in healthcare decision-making)<break/>&#8226; Ability to pay direct costs (cost of LDCT covered by Medicare and Medicaid)</td><td colspan="1" rowspan="1">&#183; Ability to reach (not tailored to personal mobility, availability of transportation, and knowledge about support services to enable access)<break/>&#183; Ability to seek (not tailored to personal and social values, culture, gender, and autonomy)<break/>&#183; Ability to pay indirect costs (associated with transportation, occupational flexibility not considered including baseline assumption around access to phone lines)</td><td colspan="1" rowspan="1">&#9746; Approachability<break/>&#9744; Acceptability<break/>&#9744; Availability<break/>&#9744; Affordability<break/>&#9746; Appropriateness</td></tr><tr><td colspan="1" rowspan="1">Balata et&#160;al. (2019)<xref rid="bib57" ref-type="bibr"><sup>57</sup></xref></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0015"><list-item id="u0015"><label>&#8226;</label><p id="p1095">55&#8211;74 years old</p></list-item><list-item id="u0020"><label>&#8226;</label><p id="p1100">Ever-smokers</p></list-item><list-item id="u0025"><label>&#8226;</label><p id="p1105">Neighborhoods identified as socioeconomically deprived on the basis of the Index of Multiple Deprivation</p></list-item><list-item id="u0030"><label>&#8226;</label><p id="p1110">PLCO risk score &#8805;1.51% over 6 years</p></list-item></list></td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0020"><list-item id="u0035"><label>&#8226;</label><p id="p1115">Ability to perceive risk (discussion around cancer risk and screening was provided)</p></list-item><list-item id="u0040"><label>&#8226;</label><p id="p1120">Ability to reach (mobile CT scanners used to deliver LDCT in convenient retail locations)</p></list-item><list-item id="u0045"><label>&#8226;</label><p id="p1125">Ability to pay (free screening and was conducted in a convenient location, resulting in minimal to no indirect costs)</p></list-item><list-item id="u0050"><label>&#8226;</label><p id="p1130">Ability to engage (patients were involved in healthcare decision-making)</p></list-item><list-item id="u0055"><label>&#8226;</label><p id="p1135">Ability to seek (tailoring of intervention to personal and social circumstances of high-risk individuals)</p></list-item></list></td><td colspan="1" rowspan="1">&#183; Availability (program dependent on registration status with primary care clinic, the accuracy of recorded smoking status, valid postal address, ability to book an appointment and participate in two rounds of LCS-further tailoring needed for populations on the basis of culture, gender, and disability)</td><td colspan="1" rowspan="1">&#9746; Approachability<break/>&#9746; Acceptability<break/>&#9744; Availability<break/>&#9746; Affordability<break/>&#9746; Appropriateness</td></tr><tr><td colspan="1" rowspan="1">Crosbie et&#160;al. (2019)<xref rid="bib61" ref-type="bibr"><sup>61</sup></xref><sup>,</sup><xref rid="bib64" ref-type="bibr"><sup>64</sup></xref></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0025"><list-item id="u0060"><label>&#8226;</label><p id="p1140">55 to 74 years old</p></list-item><list-item id="u0065"><label>&#8226;</label><p id="p1145">Ever smoker</p></list-item><list-item id="u0070"><label>&#8226;</label><p id="p1150">Neighborhoods identified as socioeconomically deprived on the basis of the Index of Multiple Deprivation</p></list-item><list-item id="u0075"><label>&#8226;</label><p id="p1155">PLCO risk score &#8805;1.51% over 6 years</p></list-item></list></td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0030"><list-item id="u0080"><label>&#8226;</label><p id="p1160">Ability to perceive risk (through mailed letters informing individuals of personal risk and inviting them to receive care including smoking cessation)</p></list-item><list-item id="u0085"><label>&#8226;</label><p id="p1165">Ability to reach (mobile scanners delivered in convenient retail locations)</p></list-item><list-item id="u0090"><label>&#8226;</label><p id="p1170">Ability to pay (free screening and was conducted immediately in a convenient location, resulting in minimal to no indirect costs)</p></list-item><list-item id="u0095"><label>&#8226;</label><p id="p1175">Ability to seek (tailoring of intervention to personal and social circumstances of high-risk individuals)</p></list-item><list-item id="u0100"><label>&#8226;</label><p id="p1180">Ability to engage (increased adherence to LCS guidelines through the delivery of LDCT immediately in community-based settings)</p></list-item></list></td><td colspan="1" rowspan="1">&#183; Availability (program dependent on registration status with primary care clinic, accuracy of recorded smoking status, valid postal address, and ability to book appointment for lung health check)</td><td colspan="1" rowspan="1">&#9746; Approachability<break/>&#9746; Acceptability<break/>&#9744; Availability<break/>&#9746; Affordability<break/>&#9746; Appropriateness</td></tr><tr><td colspan="1" rowspan="1">Giamboy (2017)<xref rid="bib56" ref-type="bibr"><sup>56</sup></xref></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0035"><list-item id="u0105"><label>&#8226;</label><p id="p1185">Individuals who meet the 2013 USPSTF guidelines for annual screening i.e.</p></list-item><list-item id="o0940"><label>55</label><p id="p1190">and 80 years of age, with at least a 30-pack-year history of smoking, who either currently smoke or quit less than 15 years</p></list-item><list-item id="u0110"><label>&#8226;</label><p id="p1195">Geographic targeting to areas with high rates of smoking and lung cancer incidence</p></list-item><list-item id="u0115"><label>&#8226;</label><p id="p1200">Geographic areas also had a high percentage of diverse individuals and were classified as low-middle social class</p></list-item></list></td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">&#183; Ability to perceive risk (received education about lung cancer risk, screening, and smoking cessation)<break/>&#183; Ability to seek (tailored to tobacco dependence, interrelated health issues with capacity for nurses to respond to social and cultural preferences)<break/>&#183; Ability to pay direct costs (cost of LDCT covered by Medicare and Medicaid)<break/>&#183; Ability to engage (patients empowered through information and education provided by a nurse)</td><td colspan="1" rowspan="1">&#183; Ability to reach (not tailored on the basis of personal mobility, availability of transportation, occupational flexibility, and linked social services)<break/>&#183; Ability to pay indirect costs (associated with transportation, occupational flexibility not considered including baseline assumption around access to phone lines)</td><td colspan="1" rowspan="1">&#9746; Approachability<break/>&#9746; Acceptability<break/>&#9744; Availability<break/>&#9744; Affordability<break/>&#9746; Appropriateness</td></tr><tr><td colspan="1" rowspan="1">Erkmen et&#160;al. (2018)<xref rid="bib32" ref-type="bibr"><sup>32</sup></xref></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0040"><list-item id="u0120"><label>&#8226;</label><p id="p1205">Individuals who meet the 2013 USPSTF guidelines for annual screening i.e.</p></list-item><list-item id="o0945"><label>55</label><p id="p1210">and 80 years of age, with at least a 30-pack-year history of smoking, who either currently smoke or quit less than 15 years</p></list-item><list-item id="u0125"><label>&#8226;</label><p id="p1215">Minority, underserved populations</p></list-item></list></td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">&#183; Ability to reach (access to SDM, LDCT, and results of the scan on the same day facilitate participation)<break/>&#183; Ability to pay direct and indirect costs (cost of LDCT covered by Medicare and Medicaid; plus ability to engage in a full suite of services at one time reduces indirect costs related to transportation and occupation)<break/>&#183; Ability to engage (SDM to better inform their healthcare decision-making)</td><td colspan="1" rowspan="1">&#183; Ability to perceive risk (referral to the program made by healthcare providers external to the program)<break/>&#183; Ability to seek (no tailoring of pathways on the basis of personal and social values, culture, gender, and autonomy)</td><td colspan="1" rowspan="1">&#9746; Approachability<break/>&#9744; Acceptability<break/>&#9744; Availability<break/>&#9746; Affordability<break/>&#9746; Appropriateness</td></tr><tr><td colspan="1" rowspan="1">Yoshida et&#160;al. (2012)<xref rid="bib65" ref-type="bibr"><sup>65</sup></xref></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0045"><list-item id="u0130"><label>&#8226;</label><p id="p1220">40&#8211;59 years old</p></list-item><list-item id="u0135"><label>&#8226;</label><p id="p1225">Living in areas with low LCS rates</p></list-item></list></td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">&#183; Ability to perceive risk (high-risk regions received information about lung cancer risk and screening by means of leaflet)</td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0050"><list-item id="u0140"><label>&#8226;</label><p id="p1230">Ability to seek (not tailored to personal and social values, culture, gender, and autonomy, and baseline assumption around access to mailing address)</p></list-item><list-item id="u0145"><label>&#8226;</label><p id="p1235">Ability to reach (not tailored on the basis of personal mobility, availability of transportation, occupational flexibility, and social services)</p></list-item></list>&#183; Ability to pay indirect costs (associated with transportation or time off work)<break/>&#183; Ability to engage (dependent on patient understanding and engaging with the content of the leaflet)</td><td colspan="1" rowspan="1">&#9746; Approachability<break/>&#9744; Acceptability<break/>&#9744; Availability<break/>&#9744; Affordability<break/>&#9744; Appropriateness</td></tr><tr><td colspan="1" rowspan="1">Begnaud et&#160;al. (2017)<xref rid="bib33" ref-type="bibr"><sup>33</sup></xref></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0055"><list-item id="u0150"><label>&#8226;</label><p id="p1240">55&#8211;79 years old</p></list-item><list-item id="u0155"><label>&#8226;</label><p id="p1245">Former smokers</p></list-item><list-item id="u0160"><label>&#8226;</label><p id="p1250">Patients actively registered and using an EHR patient portal</p></list-item></list></td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">&#183; Ability to perceive risk (received education about lung cancer risk and screening by means of an electronic messaging portal)</td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0060"><list-item id="u0165"><label>&#8226;</label><p id="p1255">Ability to seek (messaging not tailored to personal and social values, culture, gender, and autonomy)</p></list-item><list-item id="u0170"><label>&#8226;</label><p id="p1260">Ability to reach (not tailored on the basis of personal mobility, availability of transportation, occupational flexibility, and knowledge about health services to enable access)</p></list-item><list-item id="u0175"><label>&#8226;</label><p id="p1265">Ability to pay (SDM visits were not conducted as part of the study and therefore Medicare and Medicaid coverage for LCS would not apply. Indirect costs such as transportation or time off work are not accounted for. Intervention is on the basis of access to the internet and a device to support participation in care)</p></list-item><list-item id="u0180"><label>&#8226;</label><p id="p1270">Ability to engage (dependent on patient understanding and engaging with the content of the electronic message)</p></list-item></list></td><td colspan="1" rowspan="1">&#9746; Approachability<break/>&#9744; Acceptability<break/>&#9744; Availability<break/>&#9744; Affordability<break/>&#9744; Appropriateness</td></tr><tr><td colspan="1" rowspan="1">Cardarelli et&#160;al. (2017)<xref rid="bib34" ref-type="bibr"><sup>34</sup></xref></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0065"><list-item id="u0185"><label>&#8226;</label><p id="p1275">The geographic region with high rates of lung cancer incidence and mortality</p></list-item><list-item id="u0190"><label>&#8226;</label><p id="p1280">Rural communities</p></list-item></list></td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">&#183; Ability to perceive risk (received tailored campaigns around lung cancer risk and screening using multiple channels of communication)<break/>&#183; Ability to seek (campaign designed using a community-based approach and materials were tailored to personal, cultural, and social values)<break/>&#183; Ability to pay direct costs (cost of LDCT covered by Medicare and Medicaid and this was supported by materials of the campaign)</td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0070"><list-item id="u0195"><label>&#8226;</label><p id="p1285">Ability to pay indirect costs (such as transportation or time off work not accounted for)</p></list-item><list-item id="u0200"><label>&#8226;</label><p id="p1290">Ability to engage (dependent on patient understanding and engaging with the content of campaign material)</p></list-item></list></td><td colspan="1" rowspan="1">&#9746; Approachability<break/>&#9746; Acceptability<break/>&#9746; Availability<break/>&#9744; Affordability<break/>&#9744; Appropriateness</td></tr><tr><td colspan="1" rowspan="1">Dharod et&#160;al. (2019)<xref rid="bib35" ref-type="bibr"><sup>35</sup></xref></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0075"><list-item id="u0205"><label>&#8226;</label><p id="p1295">55&#8211;77 years old</p></list-item><list-item id="u0210"><label>&#8226;</label><p id="p1300">Ever-smokers</p></list-item><list-item id="u0215"><label>&#8226;</label><p id="p1305">Patients actively registered and using an EHR patient portal</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0080"><list-item id="u0220"><label>&#8226;</label><p id="p1310">No</p></list-item></list></td><td colspan="1" rowspan="1">&#183; Ability to perceive risk (received education about lung cancer risk and screening by means of an electronic messaging portal)<break/>&#183; Ability to pay direct costs (cost of LDCT can be covered by Medicare and Medicaid as SDM was part of the care pathway)</td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0085"><list-item id="u0225"><label>&#8226;</label><p id="p1315">Ability to seek (messaging not tailored to personal and social values, culture, gender, and autonomy)</p></list-item><list-item id="u0230"><label>&#8226;</label><p id="p1320">Ability to reach (not tailored on the basis of personal mobility, availability of transportation, occupational flexibility, and knowledge about health services to enable access)</p></list-item><list-item id="u0235"><label>&#8226;</label><p id="p1325">Ability to pay indirect (costs such as transportation or time off work not accounted for. Intervention is on the basis of access to the internet and a device to support participation in care)</p></list-item><list-item id="u0240"><label>&#8226;</label><p id="p1330">Ability to engage (dependent on patient understanding and engaging with the content of the electronic message before participation in SDM)</p></list-item></list></td><td colspan="1" rowspan="1">&#9746; Approachability<break/>&#9744; Acceptability<break/>&#9744; Availability<break/>&#9744; Affordability<break/>&#9744; Appropriateness</td></tr><tr><td colspan="1" rowspan="1">Veronesi et&#160;al. (2017)<xref rid="bib66" ref-type="bibr"><sup>66</sup></xref></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0090"><list-item id="u0245"><label>&#8226;</label><p id="p1335">Families living in Milan, Italy asked to identify members of the household for further participation&#8211;i.e.</p></list-item><list-item id="u0250"><label>&#8226;</label><p id="p1340">&gt; 50 years old</p></list-item><list-item id="u0255"><label>&#8226;</label><p id="p1345">Former or current smokers</p></list-item></list></td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">&#183; Ability to perceive risk (individuals were contacted at home to discuss risk and options for screening)<break/>&#183; Ability to engage (participants received smoking cessation advice to better inform their healthcare decision-making)<break/>&#183; Ability to pay direct costs (cost of LDCT covered)</td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0095"><list-item id="u0260"><label>&#8226;</label><p id="p1350">Ability to seek (unclear whether messaging was tailored to personal and social values, culture, gender, and autonomy)</p></list-item><list-item id="u0265"><label>&#8226;</label><p id="p1355">Ability to reach (intervention does not influence transportation, occupational flexibility, and other social services)</p></list-item><list-item id="u0270"><label>&#8226;</label><p id="p1360">Ability to pay indirectly (costs such as transportation or time off work not accounted for. Intervention is on the basis of access to a phone line)</p></list-item></list></td><td colspan="1" rowspan="1">&#9746; Approachability<break/>&#9744; Acceptability<break/>&#9744; Availability<break/>&#9744; Affordability<break/>&#9746; Appropriateness</td></tr><tr><td colspan="1" rowspan="1">Federman et&#160;al. (2014)<xref rid="bib36" ref-type="bibr"><sup>36</sup></xref></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0100"><list-item id="u0275"><label>&#8226;</label><p id="p1365">Age 55&#8211;74 years</p></list-item><list-item id="u0280"><label>&#8226;</label><p id="p1370">Former or current smokers</p></list-item><list-item id="u0285"><label>&#8226;</label><p id="p1375">Veterans</p></list-item></list></td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">&#183; Ability to perceive risk (received education around lung cancer risk and screening that was led by a healthcare provider)<break/>&#183; Ability to pay direct costs (cost of LDCT covered)<break/>&#183; Ability to engage (patients were involved in healthcare decision-making)</td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0105"><list-item id="u0290"><label>&#8226;</label><p id="p1380">Ability to seek (tailoring to personal and social values, culture, gender, and autonomy dependent on physician)</p></list-item><list-item id="u0295"><label>&#8226;</label><p id="p1385">Ability to reach (intervention does not influence transportation, occupational flexibility, and other social services)</p></list-item><list-item id="u0300"><label>&#8226;</label><p id="p1390">Ability to pay indirect (costs such as transportation not accounted for)</p></list-item></list></td><td colspan="1" rowspan="1">&#9746; Approachability<break/>&#9744; Acceptability<break/>&#9744; Availability<break/>&#9744; Affordability<break/>&#9746; Appropriateness</td></tr><tr><td colspan="1" rowspan="1">Mazzone et&#160;al. (2017)<xref rid="bib37" ref-type="bibr"><sup>37</sup></xref></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0110"><list-item id="u0305"><label>&#8226;</label><p id="p1395">Age 55&#8211;80 years</p></list-item><list-item id="u0310"><label>&#8226;</label><p id="p1400">Current or former smokers</p></list-item></list></td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">&#183; Ability to perceive risk (received centralized counseling and SDM, including a video to improve knowledge and understanding of LCS)<break/>&#183; Ability to engage (received SDM with a nurse, physician assistant, or physician for personalized healthcare decision-making)<break/>Ability to pay direct costs (cost of LDCT can be covered by Medicare and Medicaid as SDM was part of the care pathway)</td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0115"><list-item id="u0315"><label>&#8226;</label><p id="p1405">Ability to seek (tailoring to personal and social values, culture, gender, and autonomy dependent on referring physician)</p></list-item><list-item id="u0320"><label>&#8226;</label><p id="p1410">Ability to reach (intervention does not influence transportation, occupational flexibility, and other social services)</p></list-item><list-item id="u0325"><label>&#8226;</label><p id="p1415">Ability to pay indirect (costs such as transportation not accounted for)</p></list-item></list></td><td colspan="1" rowspan="1">&#9746; Approachability<break/>&#9744; Acceptability<break/>&#9744; Availability<break/>&#9744; Affordability<break/>&#9746; Appropriateness</td></tr><tr><td colspan="1" rowspan="1">Wang et&#160;al (2020)<xref rid="bib38" ref-type="bibr"><sup>38</sup></xref></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0120"><list-item id="u0330"><label>&#8226;</label><p id="p1420">Age 55&#8211;77 years</p></list-item><list-item id="u0335"><label>&#8226;</label><p id="p1425">Female</p></list-item><list-item id="u0340"><label>&#8226;</label><p id="p1430">Ever-smokers</p></list-item></list></td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">&#183; Ability to perceive risk (enhanced by linking one form of preventive care i.e. screening mammography to another i.e. smoking cessation and LCS eligibility)<break/>&#183; Ability to seek (program was provided in multiple languages with interpreter services available to support patients)<break/>&#183; Ability to engage (patients were offered multiple ways to receive smoking cessation and could decide what worked best for them)<break/>&#183;</td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0125"><list-item id="u0345"><label>&#8226;</label><p id="p1435">Availability (program dependent on enrolment with screening mammography. I.e. a population already engaged in health promotion and ready to engage in care)</p></list-item><list-item id="u0350"><label>&#8226;</label><p id="p1440">Ability to pay indirect (costs such as transportation not accounted for)</p></list-item></list></td><td colspan="1" rowspan="1">&#9746; Approachability<break/>&#9746; Acceptability<break/>&#9744; Availability<break/>&#9744; Affordability<break/>&#9746; Appropriateness</td></tr><tr><td colspan="1" rowspan="1">Ruparel et&#160;al. (2019)<xref rid="bib58" ref-type="bibr"><sup>58</sup></xref></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0130"><list-item id="u0355"><label>&#8226;</label><p id="p1445">Age 60&#8211;75 years</p></list-item><list-item id="u0360"><label>&#8226;</label><p id="p1450">Ever-smokers</p></list-item><list-item id="u0365"><label>&#8226;</label><p id="p1455">Patients identified as socioeconomically deprived on the basis of the Index of Multiple Deprivation</p></list-item></list></td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">&#183; Ability to perceive risk (received either a film or informational booklet on LCS)<break/>&#183; Ability to seek (social and cultural adaptation of materials with patients and healthcare providers)<break/>&#183; Ability to engage (patients were involved in healthcare decision-making through the LHC program)</td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0135"><list-item id="u0370"><label>&#8226;</label><p id="p1460">Availability (program dependent on registration status with primary care clinic, accuracy of recorded smoking status, valid postal address, and ability to book appointment for lung health check)</p></list-item><list-item id="u0375"><label>&#8226;</label><p id="p1465">Ability to pay indirect (costs such as transportation not accounted for)</p></list-item></list></td><td colspan="1" rowspan="1">&#9746; Approachability<break/>&#9746; Acceptability<break/>&#9744; Availability<break/>&#9744; Affordability<break/>&#9746; Appropriateness</td></tr><tr><td colspan="1" rowspan="1">Quaife et&#160;al.(2020)<xref rid="bib62" ref-type="bibr"><sup>62</sup></xref></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0140"><list-item id="u0380"><label>&#8226;</label><p id="p1470">Age 60&#8211;75 years</p></list-item><list-item id="u0385"><label>&#8226;</label><p id="p1475">Ever-smokers</p></list-item><list-item id="u0390"><label>&#8226;</label><p id="p1480">Patients identified as socioeconomically deprived on the basis of the Index of Multiple Deprivation</p></list-item></list></td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">&#183; Ability to perceive risk (received informational leaflets and stepped approach to knowledge about LHC and LCS)<break/>&#183; Ability to seek (social and cultural targeting of program enhanced using behavioral science models)<break/>&#183; Ability to engage (patients were involved in healthcare decision-making through the LHC program)</td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0145"><list-item id="u0395"><label>&#8226;</label><p id="p1485">Availability (program dependent on registration status with primary care clinic, accuracy of recorded smoking status, valid postal address, and ability to book appointment for lung health check)</p></list-item><list-item id="u0400"><label>&#8226;</label><p id="p1490">Ability to pay indirect (costs such as transportation not accounted for)</p></list-item></list></td><td colspan="1" rowspan="1">&#9746; Approachability<break/>&#9746; Acceptability<break/>&#9744; Availability<break/>&#9744; Affordability<break/>&#9746; Appropriateness</td></tr><tr><td colspan="1" rowspan="1">Percac-Lima et&#160;al. (2018)<xref rid="bib39" ref-type="bibr"><sup>39</sup></xref></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0150"><list-item id="u0405"><label>&#8226;</label><p id="p1495">Ages 55&#8211;77 years</p></list-item><list-item id="u0410"><label>&#8226;</label><p id="p1500">Current smokers</p></list-item><list-item id="u0415"><label>&#8226;</label><p id="p1505">Low socioeconomic status&#8211;on the basis of affiliation with community health centers and public health insurance</p></list-item></list></td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">&#183; Ability to perceive risk (received personalized smoking cessation counseling/services, including educational materials, and outreach around lung cancer risk and screening)<break/>&#183; Ability to seek (social and cultural targeting of the program to meet community needs)<break/>&#183; Ability to pay (screening covered by Medicare and addressed insurance issues relating to reimbursement and/or transportation)<break/>&#183; Ability to engage (patients were involved in healthcare decision-making at each step and facilitated by a trained patient navigator)</td><td colspan="1" rowspan="1">&#183; Ability to reach (dependent on access to a phone line to communicate with patient navigator)</td><td colspan="1" rowspan="1">&#9746; Approachability<break/>&#9746; Acceptability<break/>&#9744; Availability<break/>&#9746; Affordability<break/>&#9746; Appropriateness</td></tr><tr><td colspan="1" rowspan="1">Bartlett et&#160;al. (2020)<xref rid="bib60" ref-type="bibr"><sup>60</sup></xref></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0155"><list-item id="u0420"><label>&#8226;</label><p id="p1510">Age 60&#8211;75 years</p></list-item><list-item id="u0425"><label>&#8226;</label><p id="p1515">Ever-smokers</p></list-item><list-item id="u0430"><label>&#8226;</label><p id="p1520">Geographic tailoring to the neighborhood with the highest smoking rates and lowest reported 1-year lung cancer survival rate</p></list-item></list></td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0160"><list-item id="u0435"><label>&#183;</label><p id="p1525">Ability to perceive risk (received information by mail and assessment through LHC)</p></list-item><list-item id="u0440"><label>&#183;</label><p id="p1530">Ability to reach (mobile screening sites were provided to address barriers to access)</p></list-item><list-item id="u0445"><label>&#183;</label><p id="p1535">Ability to engage (people were active participants in the development of cancer screening materials and patients were involved in healthcare decision-making)</p></list-item><list-item id="u0450"><label>&#8226;</label><p id="p1540">Ability to pay (free screening and was conducted in a convenient location, resulting in minimal to no indirect costs)</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0165"><list-item id="u0455"><label>&#8226;</label><p id="p1545">Availability (program dependent on registration status with primary care clinic, accuracy of recorded smoking status, valid postal address, and ability to book appointment for lung health check)</p></list-item></list></td><td colspan="1" rowspan="1">&#9746; Approachability<break/>&#9746; Acceptability<break/>&#9744; Availability<break/>&#9746; Affordability<break/>&#9746; Appropriateness</td></tr><tr><td colspan="1" rowspan="1">Reuland et&#160;al. (2018)<xref rid="bib40" ref-type="bibr"><sup>40</sup></xref></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0170"><list-item id="u0460"><label>&#8226;</label><p id="p1550">Individuals who meet the 2013 USPSTF guidelines for annual screening i.e.</p></list-item></list>55 and 80 years of age, with at least a 30-pack-year history of smoking, who either currently smoke or quit less than 15 years</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">&#183; Ability to perceive risk (received an informational video on lung cancer risk and personalized risk assessment)<break/>&#183; Ability to engage (patients better equipped to have a discussion on the harms and benefits of LCS)<break/>&#183; Ability to pay direct costs (cost of LDCT can be covered by Medicare and Medicaid as SDM was part of the care pathway)</td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0175"><list-item id="u0465"><label>&#8226;</label><p id="p1555">Availability (program dependent on registration status with primary care clinic, accuracy of recorded smoking status, valid postal address, and phone line)</p></list-item><list-item id="u0470"><label>&#8226;</label><p id="p1560">Ability to seek (not tailored to personal and social values, culture, gender, and autonomy)</p></list-item><list-item id="u0475"><label>&#8226;</label><p id="p1565">Ability to pay indirect (costs such as transportation not accounted for)</p></list-item></list></td><td colspan="1" rowspan="1">&#9746; Approachability<break/>&#9744; Acceptability<break/>&#9744; Availability<break/>&#9744; Affordability<break/>&#9746; Appropriateness</td></tr><tr><td colspan="1" rowspan="1">Crosbie et&#160;al. (2019)<xref rid="bib61" ref-type="bibr"><sup>61</sup></xref><sup>,</sup><xref rid="bib64" ref-type="bibr"><sup>64</sup></xref></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0180"><list-item id="u0480"><label>&#8226;</label><p id="p1570">Ages 55&#8211;74 years</p></list-item><list-item id="u0485"><label>&#8226;</label><p id="p1575">Ever smoker</p></list-item><list-item id="u0490"><label>&#8226;</label><p id="p1580">Neighborhoods identified as socioeconomically deprived on the basis of the Index of Multiple Deprivation</p></list-item><list-item id="u0495"><label>&#8226;</label><p id="p1585">PLCO risk score &#8805;1.51% over 6 years</p></list-item></list></td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0185"><list-item id="u0500"><label>&#8226;</label><p id="p1590">Ability to perceive risk (through mailed letters informing individuals of personal risk and inviting them to receive care including smoking cessation)</p></list-item><list-item id="u0505"><label>&#8226;</label><p id="p1595">Ability to reach (mobile scanners delivered in convenient retail locations)</p></list-item><list-item id="u0510"><label>&#8226;</label><p id="p1600">Ability to seek (tailoring of intervention to personal and social circumstances of high-risk individuals)</p></list-item><list-item id="u0515"><label>&#8226;</label><p id="p1605">Ability to pay (free screening and was conducted immediately in a convenient location, resulting in minimal to no indirect costs)</p></list-item><list-item id="u0520"><label>&#8226;</label><p id="p1610">Ability to engage (increased adherence to LCS guidelines through the delivery of LDCT immediately in community-based settings)</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0190"><list-item id="u0525"><label>&#8226;</label><p id="p1615">Availability (program dependent on registration status with primary care clinic, accuracy of recorded smoking status, valid postal address, and ability to book appointment for lung health check)</p></list-item></list></td><td colspan="1" rowspan="1">&#9746; Approachability<break/>&#9746; Acceptability<break/>&#9744; Availability<break/>&#9746; Affordability<break/>&#9746; Appropriateness</td></tr><tr><td colspan="1" rowspan="1">Lam et&#160;al. (2021)<xref rid="bib41" ref-type="bibr"><sup>41</sup></xref></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0195"><list-item id="u0530"><label>&#8226;</label><p id="p1620">At least 50 years old</p></list-item><list-item id="u0535"><label>&#8226;</label><p id="p1625">Current or former smokers</p></list-item><list-item id="u0540"><label>&#8226;</label><p id="p1630">Smoking 20 packs/year</p></list-item></list></td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">&#183; Ability to perceive risk (risk assessment through genetic testing done once participants were already engaged in the program)<break/>&#183; Ability to engage (participants were involved in risk assessment and decision-making for LCS)</td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0200"><list-item id="u0545"><label>&#8226;</label><p id="p1635">Availability (program dependent on referral by a physician or need/desire to respond to advertisement)</p></list-item><list-item id="u0550"><label>&#8226;</label><p id="p1640">Ability to seek (not tailored to personal and social values, culture, gender, and autonomy)</p></list-item><list-item id="u0555"><label>&#8226;</label><p id="p1645">Ability to pay indirect (costs such as transportation not accounted for)</p></list-item></list></td><td colspan="1" rowspan="1">&#9746; Approachability<break/>&#9744; Acceptability<break/>&#9744; Availability<break/>&#9744; Affordability<break/>&#9746; Appropriateness</td></tr><tr><td colspan="1" rowspan="1">Volk et&#160;al. (2020)<xref rid="bib42" ref-type="bibr"><sup>42</sup></xref></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0205"><list-item id="u0560"><label>&#8226;</label><p id="p1650">Ages 55&#8211;77 years</p></list-item><list-item id="u0565"><label>&#8226;</label><p id="p1655">Smoked 30 pack/years or more</p></list-item><list-item id="u0570"><label>&#8226;</label><p id="p1660">English speakers</p></list-item></list></td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">&#183; Ability to perceive risk (smoking cessation Quitline leveraged to provide further information about lung cancer risk)<break/>&#183; Ability to engage (ability to participate in further education and LCS enhanced by personal outreach)</td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0210"><list-item id="u0575"><label>&#8226;</label><p id="p1665">Availability (program dependent on active engagement with the health care system through the Quitline and a willingness to stop smoking)</p></list-item><list-item id="u0580"><label>&#8226;</label><p id="p1670">Ability to seek (services were provided only in the English language)</p></list-item><list-item id="u0585"><label>&#8226;</label><p id="p1675">Ability to pay indirect (costs such as transportation not accounted for)</p></list-item></list></td><td colspan="1" rowspan="1">&#9746; Approachability<break/>&#9744; Acceptability<break/>&#9744; Availability<break/>&#9744; Affordability<break/>&#9746; Appropriateness</td></tr><tr><td colspan="1" rowspan="1">Tanner et&#160;al. (2020)<xref rid="bib43" ref-type="bibr"><sup>43</sup></xref></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0215"><list-item id="u0590"><label>&#8226;</label><p id="p1680">Ages 55&#8211;80 years</p></list-item><list-item id="u0595"><label>&#8226;</label><p id="p1685">30-pack-year smoking history</p></list-item><list-item id="u0600"><label>&#8226;</label><p id="p1690">Quit within the past 15 years</p></list-item><list-item id="u0605"><label>&#8226;</label><p id="p1695">Veterans registered with the Veterans Affairs health system</p></list-item></list></td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">&#183; Ability to perceive risk (program coordinators provide outreach to eligible patients and share information)<break/>&#183; Ability to engage (nurses and trained coordinators provide SDM and facilitate the booking of appointments)</td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0220"><list-item id="u0610"><label>&#183;</label><p id="p1700">Availability (program dependent on status as a Veteran and smoking history in the system &#8764; patient also needs an active phone line to book and schedule appointment)</p></list-item><list-item id="u0615"><label>&#183;</label><p id="p1705">Ability to seek (tailoring to personal and social values, culture, gender, and autonomy not described)</p></list-item><list-item id="u0620"><label>&#8226;</label><p id="p1710">Ability to pay costs Cost of LDCT is dependent on the veteran's level of service ($0&#8211;$50) and costs such as transportation not accounted for)</p></list-item></list></td><td colspan="1" rowspan="1">&#9746; Approachability<break/>&#9744; Acceptability<break/>&#9744; Availability<break/>&#9744; Affordability<break/>&#9746; Appropriateness</td></tr><tr><td colspan="1" rowspan="1">Kinsinger et&#160;al. (2017)<xref rid="bib44" ref-type="bibr"><sup>44</sup></xref></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0225"><list-item id="u0625"><label>&#8226;</label><p id="p1715">Age 55&#8211;80 years</p></list-item><list-item id="u0630"><label>&#8226;</label><p id="p1720">30-pack-year smoking history</p></list-item><list-item id="u0635"><label>&#8226;</label><p id="p1725">Quit within the past 15 y</p></list-item><list-item id="u0640"><label>&#8226;</label><p id="p1730">Veterans registered with the Veterans Affairs health system</p></list-item></list></td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">&#183; Ability to perceive risk (program coordinators provide outreach to eligible patients and share information)<break/>&#183; Ability to engage (nurses and trained coordinators provide SDM and facilitate the booking of appointments)</td><td colspan="1" rowspan="1">&#183; Availability (program dependent on status as a Veteran and smoking history in the system &#8764; patient also needs an active phone line to book and schedule appointment)<break/>&#183; Ability to seek (tailoring to personal and social values, culture, gender, and autonomy not described)<break/>&#183; Ability to pay costs (cost of LDCT dependent on veteran&#8217;s level of service ($0&#8211;$50) and costs such as transportation not accounted for)</td><td colspan="1" rowspan="1">&#9746; Approachability<break/>&#9744; Acceptability<break/>&#9744; Availability<break/>&#9744; Affordability<break/>&#9746; Appropriateness</td></tr><tr><td colspan="1" rowspan="1">Monu et&#160;al. (2022)<xref rid="bib45" ref-type="bibr"><sup>45</sup></xref></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0230"><list-item id="u0645"><label>-</label><p id="p1735">Age 55&#8211;80 years</p></list-item><list-item id="u0650"><label>-</label><p id="p1740">Smoked 30 pack/years or more</p></list-item><list-item id="u0655"><label>-</label><p id="p1745">Quit within the past 15 years</p></list-item><list-item id="u0660"><label>-</label><p id="p1750">Survey panelist for Mazon's Mechanical Turk (MTurk) crowdsourcing recruitment tool for survey research</p></list-item></list></td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">&#183; Ability to perceive risk (received targeted advertising on lung cancer risk and LCS)<break/>&#183; Ability to engage (intervention was designed to provoke engagement)</td><td colspan="1" rowspan="1">&#183; Ability to reach (this intervention was not carried out in the real world setting)<break/>&#183; Ability to seek (tailoring to personal and social values, culture, gender, and autonomy not described)<break/>&#183; Ability to pay costs (of LDCT and indirect costs to access care not influenced by intervention)</td><td colspan="1" rowspan="1">&#9746; Approachability<break/>&#9744; Acceptability<break/>&#9744; Availability<break/>&#9744; Affordability<break/>&#9744; Appropriateness</td></tr><tr><td colspan="1" rowspan="1">Williams et&#160;al. (2021)<xref rid="bib46" ref-type="bibr"><sup>46</sup></xref></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0235"><list-item id="u0665"><label>&#8226;</label><p id="p1755">Low socioeconomic status</p></list-item><list-item id="u0670"><label>&#8226;</label><p id="p1760">Racial/ethnic minority</p></list-item><list-item id="u0675"><label>&#8226;</label><p id="p1765">Community setting</p></list-item></list></td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">&#183; Ability to perceive risk (received education about smoking and lung cancer risk)<break/>&#183; Ability to seek (program delivered by community health workers and therefore tailored to personal and social values, culture, and gender preferences)<break/>&#183; Ability to reach (resources and tools were available to members of the community in their setting&#8211;ability to reach LDCT influenced by program)<break/>&#183; Ability to engage (community members actively involved in educating and empowering other members of the community)<break/>&#183; Ability to pay direct and some indirect costs (cost of LDCT covered by Medicare and Medicaid; ability to engage in community-based services reduces indirect costs related to risk assessment)</td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0240"><list-item id="u0680"><label>&#8226;</label><p id="p1770">Ability to pay indirectly (additional costs such as transportation or time required off work not accounted for)</p></list-item></list></td><td colspan="1" rowspan="1">&#9746; Approachability<break/>&#9746; Acceptability<break/>&#9746; Availability<break/>&#9744; Affordability<break/>&#9746; Appropriateness</td></tr><tr><td colspan="1" rowspan="1">Fabbrini et&#160;al.(2018)<xref rid="bib47" ref-type="bibr"><sup>47</sup></xref></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0245"><list-item id="u0685"><label>&#8226;</label><p id="p1775">Age 55&#8211;80 years</p></list-item><list-item id="u0690"><label>&#8226;</label><p id="p1780">30-pack-year smoking history</p></list-item><list-item id="u0695"><label>&#8226;</label><p id="p1785">Quit within the past 15 y</p></list-item><list-item id="u0700"><label>&#8226;</label><p id="p1790">Veterans registered with the Veterans Affairs health system</p></list-item></list></td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">&#183; Ability to perceive risk (program coordinators provide outreach to eligible patients and share information)<break/>&#183; Ability to engage (nurses and trained coordinators provide SDM and facilitate the booking of appointments)</td><td colspan="1" rowspan="1">&#183; Availability (program dependent on status as a Veteran and smoking history in the system &#8764; patient also needs an active phone line to book and schedule appointment)<break/>&#183; Ability to seek (tailoring to personal and social values, culture, gender, and autonomy not described)<break/>&#183; Ability to pay costs (cost of LDCT dependent on veteran's level of service ($0&#8211;$50) and costs such as transportation not accounted for)</td><td colspan="1" rowspan="1">&#9746; Approachability<break/>&#9744; Acceptability<break/>&#9744; Availability<break/>&#9744; Affordability<break/>&#9746; Appropriateness</td></tr><tr><td colspan="1" rowspan="1">Han et&#160;al.(2019)<xref rid="bib48" ref-type="bibr"><sup>48</sup></xref></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0250"><list-item id="u0705"><label>&#8226;</label><p id="p1795">Age 55&#8211;80 years</p></list-item><list-item id="u0710"><label>&#8226;</label><p id="p1800">30-pack-year smoking history</p></list-item><list-item id="u0715"><label>&#8226;</label><p id="p1805">Quit within the past 15 years</p></list-item></list></td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">&#183; Ability to perceive risk (received personalized DA, SDM, and educational materials on lung cancer risk and screening)<break/>&#183; Ability to engage (physicians provided SDM, discussion of personalized risk to promote decision-making)<break/>&#183; Ability to pay direct costs (cost of LDCT can be covered by Medicare and Medicaid as SDM was part of the care pathway)</td><td colspan="1" rowspan="1">&#183; Availability (program dependent on referral by community care practice)<break/>&#183; Ability to seek (unclear to what extent DA was tailored to personal and social values, culture, gender, and autonomy)<break/>&#183; Ability to pay indirect (costs such as transportation not accounted for)</td><td colspan="1" rowspan="1">&#9746; Approachability<break/>&#9744; Acceptability<break/>&#9744; Availability<break/>&#9744; Affordability<break/>&#9746; Appropriateness</td></tr><tr><td colspan="1" rowspan="1">Azubuike et&#160;al. (2020)<xref rid="bib49" ref-type="bibr"><sup>49</sup></xref></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0255"><list-item id="u0720"><label>&#8226;</label><p id="p1810">Age 55&#8211;80 years</p></list-item><list-item id="u0725"><label>&#8226;</label><p id="p1815">30-pack-year smoking history</p></list-item><list-item id="u0730"><label>&#8226;</label><p id="p1820">Quit within the past 15 y</p></list-item><list-item id="u0735"><label>&#8226;</label><p id="p1825">Geographic targeting to an area with high smoking prevalence and incidence of lung cancer</p></list-item></list></td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">&#183; Ability to perceive risk (providers received education and training to detect and act on patient risk)<break/>&#183; Ability to engage (providers were better equipped to discuss risk and refer patients)<break/>&#183; Ability to pay direct and some indirect costs (cost of LDCT covered by Medicare and Medicaid)<break/>&#183; Ability to pay direct costs (cost of LDCT can be covered by Medicare and Medicaid)</td><td colspan="1" rowspan="1">&#183; Ability to seek (patient-facing script was not tailored to personal and social values, culture, gender, and autonomy)<break/>&#183; Availability (program dependent on patient enrolment with practice and accurate smoking history on EHR, plus access to an active phone line)<break/>&#183; Ability to pay indirect (costs such as transportation not covered)</td><td colspan="1" rowspan="1">&#9746; Approachability<break/>&#9744; Acceptability<break/>&#9744; Availability<break/>&#9744; Affordability<break/>&#9746; Appropriateness</td></tr><tr><td colspan="1" rowspan="1">McDonnell et&#160;al. (2018)<xref rid="bib50" ref-type="bibr"><sup>50</sup></xref></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0260"><list-item id="u0740"><label>&#8226;</label><p id="p1830">Ages 55&#8211;77</p></list-item><list-item id="u0745"><label>&#8226;</label><p id="p1835">Receiving Medicaid or Medicare coverage</p></list-item></list></td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">&#183; Ability to perceive risk (patients received personalized risk assessment and SDM discussion)<break/>&#183; Ability to seek (DA tailored to lower grade level for wider accessibility)<break/>&#183; Ability to pay direct and some indirect costs (cost of LDCT covered by Medicare and Medicaid; cost of travel covered for patients who needed it)<break/>&#183; Ability to engage (influenced by tailored care pathway and tools)</td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0265"><list-item id="u0750"><label>&#8226;</label><p id="p1840">Availability (program dependent on patient enrolment with practice and accurate smoking history on EHR, plus access to an active phone line)</p></list-item></list></td><td colspan="1" rowspan="1">&#9746; Approachability<break/>&#9746; Acceptability<break/>&#9744; Availability<break/>&#9746; Affordability<break/>&#9746; Appropriateness</td></tr><tr><td colspan="1" rowspan="1">Spalluto et&#160;al. (2020)<xref rid="bib51" ref-type="bibr"><sup>51</sup></xref></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0270"><list-item id="u0755"><label>&#8226;</label><p id="p1845">Age 55&#8211;80 years</p></list-item><list-item id="u0760"><label>&#8226;</label><p id="p1850">Patients who had previously been screened for lung cancer at an institution</p></list-item></list></td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">&#183; Ability to perceive risk (patients received SDM and personalized smoking cessation from program navigator)<break/>&#183; Ability to seek (navigator positioned to tailor care to personal and social values, culture, gender, and autonomy)<break/>&#183; Ability to engage (navigator positioned to discuss risk and support uptake)<break/>&#183; Ability to pay direct costs (cost of LDCT can be covered by Medicare and Medicaid)</td><td colspan="1" rowspan="1">&#183; Availability (program dependent on referral to program/ enrolment in current program)<break/>&#183; Ability to pay indirect (costs such as transportation not covered)</td><td colspan="1" rowspan="1">&#9746; Approachability<break/>&#9746; Acceptability<break/>&#9744; Availability<break/>&#9744; Affordability<break/>&#9746; Appropriateness</td></tr><tr><td colspan="1" rowspan="1">Raz et&#160;al. (2021)<xref rid="bib52" ref-type="bibr"><sup>52</sup></xref></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0275"><list-item id="u0765"><label>&#8226;</label><p id="p1855">Age 55&#8211;80 years</p></list-item><list-item id="u0770"><label>&#8226;</label><p id="p1860">30-pack-year smoking history</p></list-item><list-item id="u0775"><label>&#8226;</label><p id="p1865">Quit within the past 15 years</p></list-item></list></td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">&#183; Ability to perceive risk (patients received an educational video on lung cancer risk and screening)<break/>&#183; Ability to engage (patients were better informed to participate in decision-making&#8211;including access to smoking cessation)</td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0280"><list-item id="u0780"><label>&#8226;</label><p id="p1870">Ability to seek (the educational video was designed with patients but unclear if there was tailoring to personal and social values, culture, and gender)</p></list-item><list-item id="u0785"><label>&#8226;</label><p id="p1875">Availability (program dependent on patient engagement with smoking cessation program, plus access to the internet, and with e-mail access)</p></list-item><list-item id="u0790"><label>&#8226;</label><p id="p1880">Ability to pay indirect (costs such as transportation not covered)</p></list-item></list></td><td colspan="1" rowspan="1">&#9746; Approachability<break/>&#9744; Acceptability<break/>&#9744; Availability<break/>&#9744; Affordability<break/>&#9746; Appropriateness</td></tr><tr><td colspan="1" rowspan="1"><xref rid="bib53" ref-type="bibr"><sup>53</sup></xref></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0285"><list-item id="u0795"><label>&#8226;</label><p id="p1885">Age 55&#8211;80 years</p></list-item><list-item id="u0800"><label>&#8226;</label><p id="p1890">30-pack-year smoking history</p></list-item><list-item id="u0805"><label>&#8226;</label><p id="p1895">Quit within the past 15 years</p></list-item><list-item id="u0810"><label>&#8226;</label><p id="p1900">Geographic area with low uptake of LCS</p></list-item></list></td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">&#183; Ability to perceive risk (patients received risk assessment and smoking cessation counseling from the program navigator)<break/>&#183; Ability to seek (navigator responded to personal and social values, culture, gender, and autonomy by liaising with other support workers if needed)<break/>&#183; Ability to engage (navigator provided outreach&#8211;multiple times if needed to inform and empower patients)<break/>&#183; Ability to pay costs (direct cost of LDCT covered by Medicare and Medicaid and indirect costs covered by support team)</td><td colspan="1" rowspan="1">&#183; Availability (program dependent on referral to program/ registration status and updated smoking history in hospital files)</td><td colspan="1" rowspan="1">&#9746; Approachability<break/>&#9746; Acceptability<break/>&#9744; Availability<break/>&#9746; Affordability<break/>&#9746; Appropriateness</td></tr><tr><td colspan="1" rowspan="1">Ghimire et&#160;al. (2019)<xref rid="bib63" ref-type="bibr"><sup>63</sup></xref></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0290"><list-item id="u0815"><label>&#8226;</label><p id="p1905">Ages 58&#8211;75 years</p></list-item><list-item id="u0820"><label>&#8226;</label><p id="p1910">Smoking history OR diagnosis of COPD</p></list-item><list-item id="u0825"><label>&#8226;</label><p id="p1915">Neighborhoods identified as socioeconomically deprived on the basis of the Index of Multiple Deprivation</p></list-item><list-item id="u0830"><label>&#8226;</label><p id="p1920">LLP risk model to determine eligibility to LDCT (risk of lung cancer over next 5 years over 5%)</p></list-item></list></td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">&#183; Ability to perceive risk (received targeted health promotion campaign, information by mail, and assessment through LHC)<break/>&#183; Ability to reach (services were provided through a regional community hub)<break/>&#183; Ability to engage (public messages, access to smoking cessation, LHC, and LDCT facilitated through the program)<break/>&#183; Ability to pay (free screening and was conducted in a convenient location, resulting in minimal to no indirect costs)</td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0295"><list-item id="u0835"><label>&#8226;</label><p id="p1925">Availability (program dependent on registration status with primary care clinic, accuracy of recorded smoking status, valid postal address, and ability to book appointment for lung health check)</p></list-item></list></td><td colspan="1" rowspan="1">&#9746; Approachability<break/>&#9746; Acceptability<break/>&#9744; Availability<break/>&#9746; Affordability<break/>&#9746; Appropriateness</td></tr><tr><td colspan="1" rowspan="1">Grover et&#160;al. (2020)<xref rid="bib59" ref-type="bibr"><sup>59</sup></xref></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0300"><list-item id="u0840"><label>&#8226;</label><p id="p1930">Ages 58&#8211;75 years</p></list-item><list-item id="u0845"><label>&#8226;</label><p id="p1935">Diagnosis of COPD</p></list-item><list-item id="u0850"><label>&#8226;</label><p id="p1940">No CT scan in the past 12 months</p></list-item><list-item id="u0855"><label>&#8226;</label><p id="p1945">10 or greater pack/year smoking history</p></list-item><list-item id="u0860"><label>&#8226;</label><p id="p1950">Neighborhoods identified as socioeconomically deprived on the basis of the Index of Multiple Deprivation</p></list-item></list></td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">&#183; Ability to perceive risk (patients identified and reached for assessment by program nurse)<break/>&#183; Ability to engage (enhanced through expanding current location of care to include lung cancer risk assessment)</td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0305"><list-item id="u0865"><label>&#8226;</label><p id="p1955">Availability (program dependent on registration status with COPD clinic and accuracy of recorded smoking status)</p></list-item><list-item id="u0870"><label>&#8226;</label><p id="p1960">Ability to seek (unclear to what extent the program was tailored to personal and social values, culture, gender, and autonomy)</p></list-item><list-item id="u0875"><label>&#8226;</label><p id="p1965">Ability to pay (LDCT was not free of cost, and indirect costs such as transportation were not accounted for)</p></list-item></list></td><td colspan="1" rowspan="1">&#9746; Approachability<break/>&#9744; Acceptability<break/>&#9744; Availability<break/>&#9744; Affordability<break/>&#9746; Appropriateness</td></tr><tr><td colspan="1" rowspan="1">Headrick et&#160;al. (2020)<xref rid="bib54" ref-type="bibr"><sup>54</sup></xref></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0310"><list-item id="u0880"><label>&#8226;</label><p id="p1970">Age 55&#8211;80 years</p></list-item><list-item id="u0885"><label>&#8226;</label><p id="p1975">30-pack-year smoking history</p></list-item><list-item id="u0890"><label>&#8226;</label><p id="p1980">Quit within the past 15 y</p></list-item><list-item id="u0895"><label>&#8226;</label><p id="p1985">Geospatial mapping to target high-risk underserved rural locations</p></list-item></list></td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">&#183; Ability to perceive risk (patients received health promotion through multiple media channels )<break/>&#183; Ability to reach (services were provided through a mobile scanner)<break/>&#183; Ability to engage (public messages, assessment of risk, and access to LDCT increased patient ability to make decisions)</td><td colspan="1" rowspan="1">&#183; Ability to seek (unclear if educational materials were tailored to personal and social values, culture, and gender)<break/>&#183; Ability to pay (cost of LDCT could be reimbursed but several opted to pay cash)</td><td colspan="1" rowspan="1">&#9746; Approachability<break/>&#9744; Acceptability<break/>&#9746; Availability<break/>&#9744; Affordability<break/>&#9746; Appropriateness</td></tr><tr><td colspan="1" rowspan="1">Peckham (2016)<xref rid="bib55" ref-type="bibr"><sup>55</sup></xref><sup>,</sup><xref rid="tbl3fnb" ref-type="table-fn">b</xref></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0315"><list-item id="u0900"><label>&#8226;</label><p id="p1990">Age 55&#8211;80 y</p></list-item><list-item id="u0905"><label>&#8226;</label><p id="p1995">30-pack-year smoking history</p></list-item><list-item id="u0910"><label>&#8226;</label><p id="p2000">Quit within the past 15 y</p></list-item></list></td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">&#183; Ability to perceive risk (patients received SDM and personalized smoking cessation from program navigator)<break/>&#183; Ability to seek (navigator positioned to tailor care to personal and social values, culture, gender, and autonomy)<break/>&#183; Ability to engage (navigator positioned to discuss risk and support uptake)<break/>&#183; Ability to pay direct costs (cost of LDCT can be covered by Medicare and Medicaid)</td><td colspan="1" rowspan="1">&#183; Availability (program dependent on referral to program/ enrolment in current program)<break/>&#183; Ability to pay indirect (costs such as transportation not covered)</td><td colspan="1" rowspan="1">&#9746; Approachability<break/>&#9746; Acceptability<break/>&#9744; Availability<break/>&#9744; Affordability<break/>&#9746; Appropriateness</td></tr></tbody></table><table-wrap-foot><fn><p>COPD, chronic obstructive pulmonary disease; CT, computed tomography; EHR, electronic health record; LCS, lung cancer screening; LDCT, low-dose computed tomography; LHC, lung health check; LLP, Liverpool Lung Project; PLCO, prostate lung colorectal and ovarian; SDM, shared decision making; USPSTF, U.S. Preventive Services Task Force.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl3fna"><label>a</label><p id="ntpara0025">Priority Populations are populations that experience the greatest burden of disease and face significant barriers to access.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl3fnb"><label>b</label><p id="ntpara0030">Peckham (2018) is a gray literature source.</p></fn></table-wrap-foot></table-wrap></p><p id="p0110">We mapped the dimensions of access according to our equity-oriented LCS framework (<xref rid="fig1" ref-type="fig">Fig.&#160;1</xref>) and analyzed whether the intervention improved the approachability, acceptability, availability, affordability, and/or appropriateness of each intervention (<xref rid="tbl3" ref-type="table">Table&#160;3</xref>). All of the interventions described in the literature improved approachability to LDCT by increasing the awareness of LCS services for at-risk populations. Fifteen studies described some type of sociocultural tailoring to the target population of the intervention, thereby improving its acceptability.<xref rid="bib34" ref-type="bibr"><sup>34</sup></xref><sup>,</sup><xref rid="bib39" ref-type="bibr"><sup>39</sup></xref><sup>,</sup><xref rid="bib46" ref-type="bibr"><sup>46</sup></xref><sup>,</sup><xref rid="bib50" ref-type="bibr"><sup>50</sup></xref><sup>,</sup><xref rid="bib51" ref-type="bibr"><sup>51</sup></xref><sup>,</sup><xref rid="bib53" ref-type="bibr"><sup>53</sup></xref><sup>,</sup><xref rid="bib55" ref-type="bibr">55</xref>, <xref rid="bib56" ref-type="bibr">56</xref>, <xref rid="bib57" ref-type="bibr">57</xref>, <xref rid="bib58" ref-type="bibr">58</xref><sup>,</sup><xref rid="bib60" ref-type="bibr">60</xref>, <xref rid="bib61" ref-type="bibr">61</xref>, <xref rid="bib62" ref-type="bibr">62</xref>, <xref rid="bib63" ref-type="bibr">63</xref>, <xref rid="bib64" ref-type="bibr">64</xref> Only three interventions increased the availability of LCS across all population groups<xref rid="bib34" ref-type="bibr"><sup>34</sup></xref><sup>,</sup><xref rid="bib46" ref-type="bibr"><sup>46</sup></xref><sup>,</sup><xref rid="bib54" ref-type="bibr"><sup>54</sup></xref> as they increased awareness of the program at the community-level and were not dependent on previous engagement or registration with the health care system or structured around access to mail or active phone lines to participate. Nine interventions improved affordability as they took into consideration both the direct (fee for LDCT) and indirect (lost income or need for transportation) costs related to participation in an LCS.<xref rid="bib32" ref-type="bibr"><sup>32</sup></xref><sup>,</sup><xref rid="bib39" ref-type="bibr"><sup>39</sup></xref><sup>,</sup><xref rid="bib50" ref-type="bibr"><sup>50</sup></xref><sup>,</sup><xref rid="bib53" ref-type="bibr"><sup>53</sup></xref><sup>,</sup><xref rid="bib57" ref-type="bibr"><sup>57</sup></xref><sup>,</sup><xref rid="bib60" ref-type="bibr"><sup>60</sup></xref><sup>,</sup><xref rid="bib61" ref-type="bibr"><sup>61</sup></xref><sup>,</sup><xref rid="bib63" ref-type="bibr"><sup>63</sup></xref><sup>,</sup><xref rid="bib64" ref-type="bibr"><sup>64</sup></xref> And finally, all but four interventions enhanced the appropriateness of LCS services by increasing levels of engagement and promoting informed decision-making. The four interventions that did not meet these criteria were patient-facing prompts or outreach materials that depended on the patient to receive, understand, and act on the intervention.<xref rid="bib33" ref-type="bibr">33</xref>, <xref rid="bib34" ref-type="bibr">34</xref>, <xref rid="bib35" ref-type="bibr">35</xref><sup>,</sup><xref rid="bib65" ref-type="bibr"><sup>65</sup></xref></p><p id="p0115">No studies mapped across all five dimensions of access. Nine studies mapped four out of five dimensions of access.<xref rid="bib39" ref-type="bibr"><sup>39</sup></xref><sup>,</sup><xref rid="bib46" ref-type="bibr"><sup>46</sup></xref><sup>,</sup><xref rid="bib50" ref-type="bibr"><sup>50</sup></xref><sup>,</sup><xref rid="bib53" ref-type="bibr"><sup>53</sup></xref><sup>,</sup><xref rid="bib57" ref-type="bibr"><sup>57</sup></xref><sup>,</sup><xref rid="bib60" ref-type="bibr"><sup>60</sup></xref><sup>,</sup><xref rid="bib61" ref-type="bibr"><sup>61</sup></xref><sup>,</sup><xref rid="bib63" ref-type="bibr"><sup>63</sup></xref> These interventions targeted priority populations, tailored materials for sociocultural acceptability, proactively considered costs related to participation, and enhanced utilization through informed decision-making. All these interventions were considerably more effective in improving access to LDCT and the uptake of LCS in priority populations.</p></sec></sec><sec id="sec4"><title>Discussion</title><p id="p0120">In our study, we sought to map interventions designed to increase the uptake of LDCT for LCS and identify knowledge and implementation gaps to inform the design, tailoring, and delivery of equity-oriented LCS. Most of the studies identified in our literature search originated from the United States (26/36) and included a component of SDM (15/36) through direct discussion, decision aids, and educational tools. In the United States, LCS is reimbursable through the Centre for Medicare and Medicaid only when SDM is clinically documented. The USPSTF has recently widened LCS eligibility by lowering the age and pack-year smoking criteria so that more individuals at risk of lung cancer can receive timely LDCT.<xref rid="bib5" ref-type="bibr"><sup>5</sup></xref> An inherent assumption in this approach is that by casting a wider eligibility net we can improve access across all at-risk groups and reduce health inequities, although evidence points to the need for risk profiling to include multiprong interventions that lower lung cancer risk, increase the accessibility of services, and promote the delivery of culturally-safe, nonstigmatizing LCS referrals.<xref rid="bib13" ref-type="bibr"><sup>13</sup></xref><sup>,</sup><xref rid="bib14" ref-type="bibr"><sup>14</sup></xref><sup>,</sup><xref rid="bib67" ref-type="bibr"><sup>67</sup></xref></p><sec id="sec4.1"><title>Implementation and Knowledge Gaps</title><p id="p0125">In our study, interventions mapped across multiple dimensions of accessibility (such as approachability, appropriateness, acceptability, availability, and/or affordability) were more likely to reach priority populations and promote participation in LCS. Interventions that were dependent on patient-level factors to determine participation were the least accessible and community-based interventions were most accessible to priority populations. In terms of the LCS pathway, most of the interventions depended on the patient having some previous contact with the health care system&#8212;either through a primary care practice, enrolment with other care pathways, smoking cessation clinics, or previous participation in lung cancer risk assessments and an active inclination toward LCS. Community-based interventions were independent of previous engagement of the patient with any health care setting and, therefore, were most accessible. Several, but not all interventions described a smoking cessation component although it is increasingly recognized that both LCS and smoking cessation must work in tandem to reap the most population-wide benefit from organized LCS. People who currently smoke and structurally underserved patients who are already disenfranchised from the health care system have the potential to be further marginalized from several of the interventions described. This represents an opportunity for future work so that we can increase the acceptability, availability, and affordability of LCS for all eligible patients.</p><p id="p0130">Limitations in our study include the terms used in our data search to identify relevant articles. We used a combination of terms to cast a wide net and to identify relevant articles (see <xref rid="appsec1" ref-type="sec">Supplementary Material 1</xref>). We have also previously published our protocol to validate our study methods.<xref rid="bib21" ref-type="bibr"><sup>21</sup></xref> However, different combinations of search terms could have potentially retrieved different results. Of particular note, our data search strategy did not capture any peer-reviewed or gray literature articles originating from Canada, Australia, or New Zealand. This can possibly explain the lack of interventions tailored to improve the uptake of LCS in indigenous communities described in our study. Nevertheless, the gap in the literature represents an important opportunity for countries with a history of colonization to prioritize LCS interventions that are indigenous-led and people-specific.</p><p id="p0135">According to the inverse equity hypothesis, new population-based health interventions can increase health inequities because of higher levels of uptake in populations that are more educated and well-resourced.<xref rid="bib68" ref-type="bibr"><sup>68</sup></xref> Structurally marginalized populations who have less availability of a variety of resources to access interventions are most likely to be left out of intervention design, particularly when planned interventions rely on a single-pronged approach to increase uptake such as education, and/or awareness.<xref rid="bib69" ref-type="bibr"><sup>69</sup></xref> To be effective in reducing health inequities through LCS it is necessary to positively discriminate toward the highest-risk populations by targeting specific uptake strategies that respond to patient-identified needs. Ideally, this should be done in a manner that does not stigmatize high-risk populations, but rather uses a participatory and inclusive<xref rid="bib70" ref-type="bibr"><sup>70</sup></xref> way to problematize care issues with patients. This can include designing interventions using a variety of tools, such as health education campaigns, incentives to participation, technologically enhanced delivery, and policy measures<xref rid="bib69" ref-type="bibr"><sup>69</sup></xref> that promote social equity and subsequent access to care. In this way, patients can guide the development of a multiprong approach to intervention design (such as education, resources, and tools) needed to maximize the availability, acceptability, and affordability of LCS interventions.</p><p id="p0140">We adapted the &#8220;Patient-Centered Access to Healthcare&#8221; conceptual framework<xref rid="bib29" ref-type="bibr"><sup>29</sup></xref> to guide our knowledge synthesis. In doing so, we developed an equity-oriented LCS framework that illustrates the interconnectedness between the structural and social determinants of health, the dimensions of access to LCS, and the LCS care pathway. The equity-oriented LCS framework (<xref rid="fig1" ref-type="fig">Fig.&#160;1</xref>) can be used by LCS program implementers to plan, design, and deliver interventions that are approachable, acceptable, available, affordable, and appropriate leading to more equitable LCS outcomes. Ultimately, multiprong interventions that engage with patients in the community setting, raise community-level awareness, target priority populations, and create pathways to care that reflect the social, cultural, and financial needs of priority populations will be needed to reduce the social gradient in lung cancer risk, incidence, and mortality.</p><p id="p0145">In conclusion, LCS has the potential to reduce mortality related to lung cancer. However, populations experiencing the highest burden of illness may inadvertently experience a widening of health inequities unless there is proactive outreach and redistribution of resources and services to match health needs. Programs can use the equity-oriented LCS framework to plan, design, and deliver more equitable LCS programs that are community-based, targeted to patient needs, tailored to sociocultural preferences, independent of previous registration/engagement with the health care system, and responsive to direct and indirect financial barriers to access.</p></sec></sec><sec id="sec5"><title>CRediT Authorship Contribution Statement</title><p id="p0150"><bold>Ambreen Sayani:</bold> Conceptualization, Methodology, Data analysis, Writing original draft &amp; editing, Visualization, Project administration, Planning and execution, Funding acquisition.</p><p id="p0155"><bold>Muhanad Ahmed Ali</bold>: Data curation, Validation, Analysis, Writing &#8211; review.</p><p id="p0160"><bold>Pooja Dey:</bold> Data curation, Analysis, Writing &#8211; review.</p><p id="p0165"><bold>Ann Marie Corrado</bold>: Conceptualization, Writing &#8211; review.</p><p id="p0170"><bold>Carolyn Ziegler:</bold> Conceptualization, Methodology, Data curation, Writing &#8211; review.</p><p id="p0175"><bold>Erika Nicholson:</bold> Analysis, Writing &#8211; review.</p><p id="p0180"><bold>Aisha Lofters:</bold> Conceptualization, Methodology, Data analysis, Supervision, Writing &#8211; review.</p></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name name-style="western"><surname>Bray</surname><given-names>F.</given-names></name><name name-style="western"><surname>Ferlay</surname><given-names>J.</given-names></name><name name-style="western"><surname>Soerjomataram</surname><given-names>I.</given-names></name><name name-style="western"><surname>Siegel</surname><given-names>R.L.</given-names></name><name name-style="western"><surname>Torre</surname><given-names>L.A.</given-names></name><name name-style="western"><surname>Jemal</surname><given-names>A.</given-names></name></person-group><article-title>Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</article-title><source>CA Cancer J Clin</source><volume>68</volume><year>2018</year><fpage>394</fpage><lpage>424</lpage><pub-id pub-id-type="pmid">30207593</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3322/caac.21492</pub-id></element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><collab>The National Lung Screening Trial Research Team</collab><name name-style="western"><surname>Aberle</surname><given-names>D.R.</given-names></name><name name-style="western"><surname>Adams</surname><given-names>A.M.</given-names></name><etal/></person-group><article-title>Reduced lung-cancer mortality with low-dose computed tomographic screening</article-title><source>N&#160;Engl J Med</source><volume>365</volume><year>2011</year><fpage>395</fpage><lpage>409</lpage><pub-id pub-id-type="pmid">21714641</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMoa1102873</pub-id><pub-id pub-id-type="pmcid">PMC4356534</pub-id></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name name-style="western"><surname>de Koning</surname><given-names>H.J.</given-names></name><name name-style="western"><surname>van der Aalst</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>de Jong</surname><given-names>P.A.</given-names></name><etal/></person-group><article-title>Reduced lung-cancer mortality with volume CT screening in a randomized trial</article-title><source>N&#160;Engl J Med</source><volume>382</volume><year>2020</year><fpage>503</fpage><lpage>513</lpage><pub-id pub-id-type="pmid">31995683</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMoa1911793</pub-id></element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name name-style="western"><surname>Lam</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tammemagi</surname><given-names>M.</given-names></name></person-group><article-title>Contemporary issues in the implementation of lung cancer screening</article-title><source>Eur Respir Rev</source><volume>30</volume><year>2021</year><pub-id pub-id-type="doi" assigning-authority="pmc">10.1183/16000617.0288-2020</pub-id><pub-id pub-id-type="pmcid">PMC9488761</pub-id><pub-id pub-id-type="pmid">34289983</pub-id></element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><collab>US Preventive Services Task Force</collab><name name-style="western"><surname>Krist</surname><given-names>A.H.</given-names></name><name name-style="western"><surname>Davidson</surname><given-names>K.W.</given-names></name><etal/></person-group><article-title>Screening for lung cancer: US Preventive Services Task Force recommendation statement</article-title><source>JAMA</source><volume>325</volume><year>2021</year><fpage>962</fpage><lpage>970</lpage><pub-id pub-id-type="pmid">33687470</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.2021.1117</pub-id></element-citation></ref><ref id="bib6"><label>6</label><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name name-style="western"><surname>Huo</surname><given-names>J.</given-names></name><name name-style="western"><surname>Shen</surname><given-names>C.</given-names></name><name name-style="western"><surname>Volk</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Shih</surname><given-names>Y.C.T.</given-names></name></person-group><article-title>Use of CT and chest radiography for lung cancer screening before and after publication of screening guidelines: intended and unintended uptake</article-title><source>JAMA Intern Med</source><volume>177</volume><year>2017</year><fpage>439</fpage><lpage>441</lpage><pub-id pub-id-type="pmid">28135349</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamainternmed.2016.9016</pub-id><pub-id pub-id-type="pmcid">PMC5893328</pub-id></element-citation></ref><ref id="bib7"><label>7</label><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name name-style="western"><surname>Rai</surname><given-names>A.</given-names></name><name name-style="western"><surname>Doria-Rose</surname><given-names>V.P.</given-names></name><name name-style="western"><surname>Silvestri</surname><given-names>G.A.</given-names></name><name name-style="western"><surname>Yabroff</surname><given-names>K.R.</given-names></name></person-group><article-title>Evaluating lung cancer screening uptake, outcomes, and costs in the United States: challenges with existing data and recommendations for improvement</article-title><source>JNCI J Natl Cancer Inst</source><volume>111</volume><year>2019</year><fpage>342</fpage><lpage>349</lpage><pub-id pub-id-type="pmid">30698792</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jnci/djy228</pub-id><pub-id pub-id-type="pmcid">PMC6657438</pub-id></element-citation></ref><ref id="bib8"><label>8</label><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name name-style="western"><surname>Tailor</surname><given-names>T.D.</given-names></name><name name-style="western"><surname>Tong</surname><given-names>B.C.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>J.</given-names></name><name name-style="western"><surname>Henderson</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>Choudhury</surname><given-names>K.R.</given-names></name><name name-style="western"><surname>Rubin</surname><given-names>G.D.</given-names></name></person-group><article-title>Utilization of lung cancer screening in the&#160;Medicare fee-for-service population</article-title><source>Chest</source><volume>158</volume><year>2020</year><fpage>2200</fpage><lpage>2210</lpage><pub-id pub-id-type="pmid">32562612</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.chest.2020.05.592</pub-id></element-citation></ref><ref id="bib9"><label>9</label><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name name-style="western"><surname>Yong</surname><given-names>P.C.</given-names></name><name name-style="western"><surname>Sigel</surname><given-names>K.</given-names></name><name name-style="western"><surname>Rehmani</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wisnivesky</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kale</surname><given-names>M.S.</given-names></name></person-group><article-title>Lung cancer screening uptake in the United States</article-title><source>Chest</source><volume>157</volume><year>2020</year><fpage>236</fpage><lpage>238</lpage><pub-id pub-id-type="pmid">31916962</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.chest.2019.08.2176</pub-id><pub-id pub-id-type="pmcid">PMC7609956</pub-id></element-citation></ref><ref id="bib10"><label>10</label><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name name-style="western"><surname>Zahnd</surname><given-names>W.E.</given-names></name><name name-style="western"><surname>Eberth</surname><given-names>J.M.</given-names></name></person-group><article-title>Lung cancer screening utilization: a behavioral risk factor surveillance system analysis</article-title><source>Am J Prev Med</source><volume>57</volume><year>2019</year><fpage>250</fpage><lpage>255</lpage><pub-id pub-id-type="pmid">31248742</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.amepre.2019.03.015</pub-id></element-citation></ref><ref id="bib11"><label>11</label><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name name-style="western"><surname>Ali</surname><given-names>N.</given-names></name><name name-style="western"><surname>Lifford</surname><given-names>K.J.</given-names></name><name name-style="western"><surname>Carter</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial</article-title><source>BMJ Open</source><volume>5</volume><year>2015</year><object-id pub-id-type="publisher-id">e008254</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmjopen-2015-008254</pub-id><pub-id pub-id-type="pmcid">PMC4513485</pub-id><pub-id pub-id-type="pmid">26173719</pub-id></element-citation></ref><ref id="bib12"><label>12</label><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name name-style="western"><surname>Asgary</surname><given-names>R.</given-names></name></person-group><article-title>Cancer screening in the homeless population</article-title><source>Lancet Oncol</source><volume>19</volume><year>2018</year><fpage>e344</fpage><lpage>e350</lpage><pub-id pub-id-type="pmid">30084381</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S1470-2045(18)30200-6</pub-id></element-citation></ref><ref id="bib13"><label>13</label><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name name-style="western"><surname>Sayani</surname><given-names>A.</given-names></name><name name-style="western"><surname>Vahabi</surname><given-names>M.</given-names></name><name name-style="western"><surname>O&#8217;Brien</surname><given-names>M.A.</given-names></name><etal/></person-group><article-title>Advancing health equity in cancer care: the lived experiences of poverty and access to lung cancer screening</article-title><source>PLoS One</source><volume>16</volume><year>2021</year><object-id pub-id-type="publisher-id">e0251264</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0251264</pub-id><pub-id pub-id-type="pmcid">PMC8101716</pub-id><pub-id pub-id-type="pmid">33956861</pub-id></element-citation></ref><ref id="bib14"><label>14</label><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name name-style="western"><surname>Sayani</surname><given-names>A.</given-names></name><name name-style="western"><surname>Vahabi</surname><given-names>M.</given-names></name><name name-style="western"><surname>O&#8217;Brien</surname><given-names>M.A.</given-names></name><etal/></person-group><article-title>Perspectives of family physicians towards access to lung cancer screening for individuals living with low income &#8211; a qualitative study</article-title><source>BMC Fam Pract</source><volume>22</volume><year>2021</year><fpage>10</fpage><pub-id pub-id-type="pmid">33413135</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12875-020-01354-z</pub-id><pub-id pub-id-type="pmcid">PMC7791696</pub-id></element-citation></ref><ref id="bib15"><label>15</label><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name name-style="western"><surname>Suh</surname><given-names>K.J.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>K.H.</given-names></name><name name-style="western"><surname>Lim</surname><given-names>J.</given-names></name><name name-style="western"><surname>Park</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Choi</surname><given-names>I.S.</given-names></name></person-group><article-title>Lung cancer in homeless people: clinical outcomes and cost analysis in a single institute</article-title><source>Can Respir J</source><volume>2016</volume><year>2016</year><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2016/3727689</pub-id><pub-id pub-id-type="pmcid">PMC4904509</pub-id><pub-id pub-id-type="pmid">27445531</pub-id></element-citation></ref><ref id="bib16"><label>16</label><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name name-style="western"><surname>Carter-Harris</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ceppa</surname><given-names>D.P.</given-names></name><name name-style="western"><surname>Hanna</surname><given-names>N.</given-names></name><name name-style="western"><surname>Rawl</surname><given-names>S.M.</given-names></name></person-group><article-title>Lung cancer screening: what do long-term smokers know and believe?</article-title><source>Health Expect</source><volume>20</volume><year>2017</year><fpage>59</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">26701339</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/hex.12433</pub-id><pub-id pub-id-type="pmcid">PMC4919238</pub-id></element-citation></ref><ref id="bib17"><label>17</label><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name name-style="western"><surname>Mitra</surname><given-names>D.</given-names></name></person-group><article-title>Social determinants of lung cancer incidence in Canada: A 13-year prospective study</article-title><source>Health Rep</source><volume>26</volume><year>2015</year><fpage>11</fpage><pub-id pub-id-type="pmid">26086335</pub-id></element-citation></ref><ref id="bib18"><label>18</label><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name name-style="western"><surname>Tetzlaff</surname><given-names>F.</given-names></name><name name-style="western"><surname>Epping</surname><given-names>J.</given-names></name><name name-style="western"><surname>Tetzlaff</surname><given-names>J.</given-names></name><name name-style="western"><surname>Golpon</surname><given-names>H.</given-names></name><name name-style="western"><surname>Geyer</surname><given-names>S.</given-names></name></person-group><article-title>Socioeconomic inequalities in lung cancer &#8211; a time trend analysis with German health insurance data</article-title><source>BMC Public Health</source><volume>21</volume><year>2021</year><fpage>538</fpage><pub-id pub-id-type="pmid">33740928</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12889-021-10576-4</pub-id><pub-id pub-id-type="pmcid">PMC7977592</pub-id></element-citation></ref><ref id="bib19"><label>19</label><element-citation publication-type="journal" id="sref19"><person-group person-group-type="author"><name name-style="western"><surname>Sayani</surname><given-names>A.</given-names></name></person-group><article-title>Health equity in national cancer control plans: an analysis of the Ontario cancer plan</article-title><source>Int J Health Policy Manag</source><volume>8</volume><year>2019</year><fpage>550</fpage><lpage>556</lpage><pub-id pub-id-type="pmid">31657177</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.15171/ijhpm.2019.40</pub-id><pub-id pub-id-type="pmcid">PMC6815982</pub-id></element-citation></ref><ref id="bib20"><label>20</label><element-citation publication-type="other" id="sref20"><person-group person-group-type="author"><collab>Public Health Ontario</collab></person-group><article-title>Priority populations</article-title><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.publichealthontario.ca/en/BrowseByTopic/HealthPromotion/Pages/Priority-Populations.aspx" id="intref0020">https://www.publichealthontario.ca/en/BrowseByTopic/HealthPromotion/Pages/Priority-Populations.aspx</ext-link></element-citation></ref><ref id="bib21"><label>21</label><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name name-style="western"><surname>Sayani</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ali</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Corrado</surname><given-names>A.M.</given-names></name><etal/></person-group><article-title>Interventions designed to increase the uptake of lung cancer screening and implications for priority populations: a scoping review protocol</article-title><source>BMJ Open</source><volume>11</volume><year>2021</year><object-id pub-id-type="publisher-id">e050056</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmjopen-2021-050056</pub-id><pub-id pub-id-type="pmcid">PMC8320256</pub-id><pub-id pub-id-type="pmid">34321305</pub-id></element-citation></ref><ref id="bib22"><label>22</label><element-citation publication-type="other" id="sref22"><person-group person-group-type="author"><collab>Canadian Partnership Against Cancer</collab></person-group><article-title>Lung cancer and equity: a focus on income and geogrephy</article-title><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://s22457.pcdn.co/wp-content/uploads/2020/11/Lung-cancer-and-equity-report-EN.pdf" id="intref0025">https://s22457.pcdn.co/wp-content/uploads/2020/11/Lung-cancer-and-equity-report-EN.pdf</ext-link></element-citation></ref><ref id="bib23"><label>23</label><element-citation publication-type="journal" id="sref23"><person-group person-group-type="author"><name name-style="western"><surname>Tricco</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Lillie</surname><given-names>E.</given-names></name><name name-style="western"><surname>Zarin</surname><given-names>W.</given-names></name><etal/></person-group><article-title>PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation</article-title><source>Ann Intern Med</source><volume>169</volume><year>2018</year><fpage>467</fpage><lpage>473</lpage><pub-id pub-id-type="pmid">30178033</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7326/M18-0850</pub-id></element-citation></ref><ref id="bib24"><label>24</label><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name name-style="western"><surname>Arksey</surname><given-names>H.</given-names></name><name name-style="western"><surname>O&#8217;Malley</surname><given-names>L.</given-names></name></person-group><article-title>Scoping studies: towards a methodological framework</article-title><source>Int J Soc Res Methodol</source><volume>8</volume><year>2005</year><fpage>19</fpage><lpage>32</lpage></element-citation></ref><ref id="bib25"><label>25</label><element-citation publication-type="journal" id="sref25"><person-group person-group-type="author"><name name-style="western"><surname>Babineau</surname><given-names>J.</given-names></name></person-group><article-title>Product review: Covidence (systematic review software)</article-title><source>J&#160;Assoc Bibl S Can</source><volume>35</volume><year>2014</year><fpage>68</fpage><lpage>71</lpage></element-citation></ref><ref id="bib26"><label>26</label><element-citation publication-type="journal" id="sref26"><person-group person-group-type="author"><name name-style="western"><surname>Hoffmann</surname><given-names>T.C.</given-names></name><name name-style="western"><surname>Glasziou</surname><given-names>P.P.</given-names></name><name name-style="western"><surname>Boutron</surname><given-names>I.</given-names></name><etal/></person-group><article-title>Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide</article-title><source>BMJ</source><volume>348</volume><year>2014</year><comment>g1687&#8211;g1687</comment><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj.g1687</pub-id><pub-id pub-id-type="pmid">24609605</pub-id></element-citation></ref><ref id="bib27"><label>27</label><element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name name-style="western"><surname>Turner</surname><given-names>L.</given-names></name><name name-style="western"><surname>Shamseer</surname><given-names>L.</given-names></name><name name-style="western"><surname>Altman</surname><given-names>D.G.</given-names></name><etal/></person-group><article-title>Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomized controlled trials (RCTs) published in medical journals</article-title><source>Cochrane Database Syst Rev</source><volume>11</volume><year>2012</year><object-id pub-id-type="publisher-id">MR000030</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/14651858.MR000030.pub2</pub-id><pub-id pub-id-type="pmcid">PMC7386818</pub-id><pub-id pub-id-type="pmid">23152285</pub-id></element-citation></ref><ref id="bib28"><label>28</label><element-citation publication-type="other" id="sref28"><person-group person-group-type="author"><collab>Ministry of Health and Long Term Care</collab></person-group><article-title>Health Equity Impact Assessment (Heian) Tool</article-title><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.health.gov.on.ca/en/pro/programs/heia/docs/template.pdf" id="intref0030">http://www.health.gov.on.ca/en/pro/programs/heia/docs/template.pdf</ext-link></element-citation></ref><ref id="bib29"><label>29</label><element-citation publication-type="journal" id="sref29"><person-group person-group-type="author"><name name-style="western"><surname>Khanassov</surname><given-names>V.</given-names></name><name name-style="western"><surname>Pluye</surname><given-names>P.</given-names></name><name name-style="western"><surname>Descoteaux</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Organizational interventions improving access to community-based primary health care for vulnerable populations: a scoping review</article-title><source>Int J Equity Health</source><volume>15</volume><year>2016</year><fpage>168</fpage><pub-id pub-id-type="pmid">27724952</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12939-016-0459-9</pub-id><pub-id pub-id-type="pmcid">PMC5057425</pub-id></element-citation></ref><ref id="bib30"><label>30</label><element-citation publication-type="journal" id="sref30"><person-group person-group-type="author"><name name-style="western"><surname>Levesque</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>Harris</surname><given-names>M.F.</given-names></name><name name-style="western"><surname>Russell</surname><given-names>G.</given-names></name></person-group><article-title>Patient-centred access to health care: conceptualising access at the interface of health systems and populations</article-title><source>Int J Equity Health</source><volume>12</volume><year>2013</year><fpage>18</fpage><pub-id pub-id-type="pmid">23496984</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1475-9276-12-18</pub-id><pub-id pub-id-type="pmcid">PMC3610159</pub-id></element-citation></ref><ref id="bib31"><label>31</label><element-citation publication-type="journal" id="sref31"><person-group person-group-type="author"><name name-style="western"><surname>Fagan</surname><given-names>H.B.</given-names></name><name name-style="western"><surname>Fournakis</surname><given-names>N.A.</given-names></name><name name-style="western"><surname>Jurkovitz</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Telephone-based shared decision-making for lung cancer screening in primary care</article-title><source>J&#160;Cancer Educ</source><volume>35</volume><year>2020</year><fpage>766</fpage><lpage>773</lpage><pub-id pub-id-type="pmid">31069714</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s13187-019-01528-z</pub-id><pub-id pub-id-type="pmcid">PMC7363665</pub-id></element-citation></ref><ref id="bib32"><label>32</label><element-citation publication-type="journal" id="sref32"><person-group person-group-type="author"><name name-style="western"><surname>Erkmen</surname><given-names>C.P.</given-names></name><name name-style="western"><surname>Mitchell</surname><given-names>M.</given-names></name><name name-style="western"><surname>Randhawa</surname><given-names>S.</given-names></name><etal/></person-group><article-title>An enhanced shared decision making model to address willingness and ability to undergo lung cancer screening and follow-up treatment in minority underserved populations</article-title><source>J&#160;Community Health</source><volume>43</volume><year>2018</year><fpage>27</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">28612174</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10900-017-0383-y</pub-id></element-citation></ref><ref id="bib33"><label>33</label><element-citation publication-type="journal" id="sref33"><person-group person-group-type="author"><name name-style="western"><surname>Begnaud</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Joseph</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Lindgren</surname><given-names>B.R.</given-names></name></person-group><article-title>Randomized electronic promotion of lung cancer screening: a pilot</article-title><source>JCO Clin Cancer Inform</source><volume>1</volume><year>2017</year><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1200/CCI.17.00033</pub-id><pub-id pub-id-type="pmcid">PMC6874003</pub-id><pub-id pub-id-type="pmid">30657381</pub-id></element-citation></ref><ref id="bib34"><label>34</label><element-citation publication-type="journal" id="sref34"><person-group person-group-type="author"><name name-style="western"><surname>Cardarelli</surname><given-names>R.</given-names></name><name name-style="western"><surname>Reese</surname><given-names>D.</given-names></name><name name-style="western"><surname>Roper</surname><given-names>K.L.</given-names></name><etal/></person-group><article-title>Terminate Lung Cancer (TLC) Study - a mixed-methods population approach to increase lung cancer screening awareness and low-dose computed tomography in Eastern Kentucky</article-title><source>Cancer Epidemiol</source><volume>46</volume><year>2017</year><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">27866066</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.canep.2016.11.003</pub-id><pub-id pub-id-type="pmcid">PMC5369643</pub-id></element-citation></ref><ref id="bib35"><label>35</label><element-citation publication-type="journal" id="sref35"><person-group person-group-type="author"><name name-style="western"><surname>Dharod</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bellinger</surname><given-names>C.</given-names></name><name name-style="western"><surname>Foley</surname><given-names>K.</given-names></name><name name-style="western"><surname>Case</surname><given-names>L.D.</given-names></name><name name-style="western"><surname>Miller</surname><given-names>D.</given-names></name></person-group><article-title>The reach and feasibility of an interactive lung cancer screening decision aid Delivered by Patient Portal</article-title><source>Appl Clin Inform</source><volume>10</volume><year>2019</year><fpage>19</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">30625501</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1055/s-0038-1676807</pub-id><pub-id pub-id-type="pmcid">PMC8438623</pub-id></element-citation></ref><ref id="bib36"><label>36</label><element-citation publication-type="journal" id="sref36"><person-group person-group-type="author"><name name-style="western"><surname>Federman</surname><given-names>D.G.</given-names></name><name name-style="western"><surname>Kravetz</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Lerz</surname><given-names>K.A.</given-names></name><etal/></person-group><article-title>Implementation of an electronic clinical reminder to improve rates of lung cancer screening</article-title><source>Am J Med</source><volume>127</volume><year>2014</year><fpage>813</fpage><lpage>816</lpage><pub-id pub-id-type="pmid">24769298</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.amjmed.2014.04.010</pub-id></element-citation></ref><ref id="bib37"><label>37</label><element-citation publication-type="journal" id="sref37"><person-group person-group-type="author"><name name-style="western"><surname>Mazzone</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>Tenenbaum</surname><given-names>A.</given-names></name><name name-style="western"><surname>Seeley</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Impact of a lung cancer screening counseling and shared decision-making visit</article-title><source>Chest</source><volume>151</volume><year>2017</year><fpage>572</fpage><lpage>578</lpage><pub-id pub-id-type="pmid">27815154</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.chest.2016.10.027</pub-id></element-citation></ref><ref id="bib38"><label>38</label><element-citation publication-type="journal" id="sref38"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>G.X.</given-names></name><name name-style="western"><surname>Narayan</surname><given-names>A.K.</given-names></name><name name-style="western"><surname>Park</surname><given-names>E.R.</given-names></name><name name-style="western"><surname>Lehman</surname><given-names>C.D.</given-names></name><name name-style="western"><surname>Gorenstein</surname><given-names>J.T.</given-names></name><name name-style="western"><surname>Flores</surname><given-names>E.J.</given-names></name></person-group><article-title>Screening mammography visits as opportunities to engage smokers with tobacco cessation services and lung cancer screening</article-title><source>J&#160;Am Coll Rad</source><volume>17</volume><year>2020</year><fpage>606</fpage><lpage>612</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jacr.2019.12.008</pub-id><pub-id pub-id-type="pmid">31930983</pub-id></element-citation></ref><ref id="bib39"><label>39</label><element-citation publication-type="journal" id="sref39"><person-group person-group-type="author"><name name-style="western"><surname>Percac-Lima</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ashburner</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Rigotti</surname><given-names>N.A.</given-names></name><etal/></person-group><article-title>Patient navigation for lung cancer screening among current smokers in community health centers a randomized controlled trial</article-title><source>Cancer Med</source><volume>7</volume><year>2018</year><fpage>894</fpage><lpage>902</lpage><pub-id pub-id-type="pmid">29464877</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cam4.1297</pub-id><pub-id pub-id-type="pmcid">PMC5852345</pub-id></element-citation></ref><ref id="bib40"><label>40</label><element-citation publication-type="journal" id="sref40"><person-group person-group-type="author"><name name-style="western"><surname>Reuland</surname><given-names>D.S.</given-names></name><name name-style="western"><surname>Cubillos</surname><given-names>L.</given-names></name><name name-style="western"><surname>Brenner</surname><given-names>A.T.</given-names></name><name name-style="western"><surname>Harris</surname><given-names>R.P.</given-names></name><name name-style="western"><surname>Minish</surname><given-names>B.</given-names></name><name name-style="western"><surname>Pignone</surname><given-names>M.P.</given-names></name></person-group><article-title>A&#160;pre-post study testing a lung cancer screening decision aid in primary care</article-title><source>BMC Med Inform Decis Mak</source><volume>18</volume><year>2018</year><fpage>5</fpage><pub-id pub-id-type="pmid">29325548</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12911-018-0582-1</pub-id><pub-id pub-id-type="pmcid">PMC5765651</pub-id></element-citation></ref><ref id="bib41"><label>41</label><element-citation publication-type="journal" id="sref41"><person-group person-group-type="author"><name name-style="western"><surname>Lam</surname><given-names>V.K.</given-names></name><name name-style="western"><surname>Scott</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Billings</surname><given-names>P.</given-names></name><name name-style="western"><surname>Cabebe</surname><given-names>E.</given-names></name><name name-style="western"><surname>Young</surname><given-names>R.P.</given-names></name></person-group><article-title>Utility of incorporating a gene-based lung cancer risk test on uptake and adherence in a community-based lung cancer screening pilot study</article-title><source>Prev Med Rep</source><volume>23</volume><year>2021</year><object-id pub-id-type="publisher-id">101397</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.pmedr.2021.101397</pub-id><pub-id pub-id-type="pmcid">PMC8142278</pub-id><pub-id pub-id-type="pmid">34040933</pub-id></element-citation></ref><ref id="bib42"><label>42</label><element-citation publication-type="journal" id="sref42"><person-group person-group-type="author"><name name-style="western"><surname>Volk</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Lowenstein</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>Leal</surname><given-names>V.B.</given-names></name><etal/></person-group><article-title>Effect of a patient decision aid on lung cancer screening decision-making by persons who smoke: a randomized clinical trial</article-title><source>JAMA Netw Open</source><volume>3</volume><year>2020</year><object-id pub-id-type="publisher-id">e1920362</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamanetworkopen.2019.20362</pub-id><pub-id pub-id-type="pmcid">PMC7042872</pub-id><pub-id pub-id-type="pmid">32003822</pub-id></element-citation></ref><ref id="bib43"><label>43</label><element-citation publication-type="journal" id="sref43"><person-group person-group-type="author"><name name-style="western"><surname>Tanner</surname><given-names>N.T.</given-names></name><name name-style="western"><surname>Brasher</surname><given-names>P.B.</given-names></name><name name-style="western"><surname>Wojciechowski</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Screening adherence in the Veterans Administration lung cancer screening demonstration project</article-title><source>Chest</source><volume>158</volume><year>2020</year><fpage>1742</fpage><lpage>1752</lpage><pub-id pub-id-type="pmid">32439505</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.chest.2020.04.063</pub-id></element-citation></ref><ref id="bib44"><label>44</label><element-citation publication-type="journal" id="sref44"><person-group person-group-type="author"><name name-style="western"><surname>Kinsinger</surname><given-names>L.S.</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>C.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Implementation of lung cancer screening in the Veterans Health Administration</article-title><source>JAMA Intern Med</source><volume>177</volume><year>2017</year><fpage>399</fpage><lpage>406</lpage><pub-id pub-id-type="pmid">28135352</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamainternmed.2016.9022</pub-id></element-citation></ref><ref id="bib45"><label>45</label><element-citation publication-type="journal" id="sref45"><person-group person-group-type="author"><name name-style="western"><surname>Monu</surname><given-names>J.I.</given-names></name><name name-style="western"><surname>Achar</surname><given-names>C.</given-names></name><name name-style="western"><surname>Wood</surname><given-names>D.E.</given-names></name><name name-style="western"><surname>Flum</surname><given-names>D.R.</given-names></name><name name-style="western"><surname>Agrawal</surname><given-names>N.</given-names></name><name name-style="western"><surname>Farjah</surname><given-names>F.</given-names></name></person-group><article-title>Psychological traits and the persuasiveness of lung cancer screening health messages</article-title><source>Ann Thorac Surg</source><volume>113</volume><year>2022</year><fpage>1341</fpage><lpage>1347</lpage><pub-id pub-id-type="pmid">33957098</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.athoracsur.2021.04.047</pub-id><pub-id pub-id-type="pmcid">PMC8563489</pub-id></element-citation></ref><ref id="bib46"><label>46</label><element-citation publication-type="journal" id="sref46"><person-group person-group-type="author"><name name-style="western"><surname>Williams</surname><given-names>L.B.</given-names></name><name name-style="western"><surname>Looney</surname><given-names>S.W.</given-names></name><name name-style="western"><surname>Joshua</surname><given-names>T.</given-names></name><name name-style="western"><surname>McCall</surname><given-names>A.</given-names></name><name name-style="western"><surname>Tingen</surname><given-names>M.S.</given-names></name></person-group><article-title>Promoting community awareness of lung cancer screening among disparate populations: results of the cancer-community awareness access research and education project</article-title><source>Cancer Nurs</source><volume>44</volume><year>2021</year><fpage>89</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">31599751</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/NCC.0000000000000748</pub-id></element-citation></ref><ref id="bib47"><label>47</label><element-citation publication-type="journal" id="sref47"><person-group person-group-type="author"><name name-style="western"><surname>Fabbrini</surname><given-names>A.E.</given-names></name><name name-style="western"><surname>Lillie</surname><given-names>S.E.</given-names></name><name name-style="western"><surname>Partin</surname><given-names>M.R.</given-names></name><etal/></person-group><article-title>Initial results of a lung cancer screening demonstration project: a local program evaluation</article-title><source>Am J Manag Care</source><volume>24</volume><year>2018</year><fpage>272</fpage><lpage>277</lpage><pub-id pub-id-type="pmid">29939501</pub-id></element-citation></ref><ref id="bib48"><label>48</label><element-citation publication-type="journal" id="sref48"><person-group person-group-type="author"><name name-style="western"><surname>Han</surname><given-names>P.K.J.</given-names></name><name name-style="western"><surname>Lary</surname><given-names>C.</given-names></name><name name-style="western"><surname>Black</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Effects of personalized risk information on patients referred for lung cancer screening with low-dose CT</article-title><source>Med Decis Mak</source><volume>39</volume><year>2019</year><fpage>950</fpage><lpage>961</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0272989X19875966</pub-id><pub-id pub-id-type="pmcid">PMC7335264</pub-id><pub-id pub-id-type="pmid">31631776</pub-id></element-citation></ref><ref id="bib49"><label>49</label><element-citation publication-type="journal" id="sref49"><person-group person-group-type="author"><name name-style="western"><surname>Azubuike</surname><given-names>U.C.</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>D.</given-names></name><name name-style="western"><surname>Aplin-Snider</surname><given-names>C.</given-names></name></person-group><article-title>Using United States Preventive Services Task Force guidelines to improve a family medicine clinic&#8217;s lung cancer screening rates: a quality improvement project</article-title><source>J&#160;Nurse Pract</source><volume>16</volume><year>2020</year><fpage>e169</fpage><lpage>e172</lpage></element-citation></ref><ref id="bib50"><label>50</label><element-citation publication-type="journal" id="sref50"><person-group person-group-type="author"><name name-style="western"><surname>McDonnell</surname><given-names>K.K.</given-names></name><name name-style="western"><surname>Strayer</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Sercy</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Developing and testing a brief clinic-based lung cancer screening decision aid for primary care settings</article-title><source>Health Expect</source><volume>21</volume><year>2018</year><fpage>796</fpage><lpage>804</lpage><pub-id pub-id-type="pmid">29473696</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/hex.12675</pub-id><pub-id pub-id-type="pmcid">PMC6117480</pub-id></element-citation></ref><ref id="bib51"><label>51</label><element-citation publication-type="journal" id="sref51"><person-group person-group-type="author"><name name-style="western"><surname>Spalluto</surname><given-names>L.B.</given-names></name><name name-style="western"><surname>Lewis</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>LaBaze</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Association of a lung screening program coordinator with adherence to annual CT lung screening at a large academic institution</article-title><source>J&#160;Am Coll Radiol</source><volume>17</volume><year>2020</year><fpage>208</fpage><lpage>215</lpage><pub-id pub-id-type="pmid">31499025</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jacr.2019.08.010</pub-id><pub-id pub-id-type="pmcid">PMC7767624</pub-id></element-citation></ref><ref id="bib52"><label>52</label><element-citation publication-type="journal" id="sref52"><person-group person-group-type="author"><name name-style="western"><surname>Raz</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Ismail</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Haupt</surname><given-names>E.C.</given-names></name><etal/></person-group><article-title>Improving utilization of lung cancer screening through incorporating a video-based educational tool into Smoking Cessation counseling</article-title><source>Clin Lung Cancer</source><volume>22</volume><year>2021</year><fpage>83</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">33436279</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cllc.2020.12.003</pub-id></element-citation></ref><ref id="bib53"><label>53</label><element-citation publication-type="journal" id="sref53"><person-group person-group-type="author"><name name-style="western"><surname>Watson</surname><given-names>J.</given-names></name><name name-style="western"><surname>Broome</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>S.M.</given-names></name></person-group><article-title>Low-dose computed tomography: effects of oncology nurse navigation on lung cancer screening</article-title><source>Clin J Oncol Nurs</source><volume>24</volume><year>2020</year><fpage>421</fpage><lpage>429</lpage><pub-id pub-id-type="pmid">32678377</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1188/20.CJON.421-429</pub-id></element-citation></ref><ref id="bib54"><label>54</label><element-citation publication-type="journal" id="sref54"><person-group person-group-type="author"><name name-style="western"><surname>Headrick</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Morin</surname><given-names>O.</given-names></name><name name-style="western"><surname>Miller</surname><given-names>A.D.</given-names></name><name name-style="western"><surname>Hill</surname><given-names>L.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>J.</given-names></name></person-group><article-title>Mobile lung screening: should we all get on the bus?</article-title><source>Ann Thorac Surg</source><volume>110</volume><year>2020</year><fpage>1147</fpage><lpage>1152</lpage><pub-id pub-id-type="pmid">32680629</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.athoracsur.2020.03.093</pub-id></element-citation></ref><ref id="bib55"><label>55</label><element-citation publication-type="journal" id="sref55"><person-group person-group-type="author"><name name-style="western"><surname>Peckham</surname><given-names>J.</given-names></name></person-group><article-title>Engaging patients &amp; assisting primary care physicians in lung cancer screening</article-title><source>Oncol Issues</source><volume>31</volume><year>2016</year><fpage>30</fpage><lpage>35</lpage></element-citation></ref><ref id="bib56"><label>56</label><element-citation publication-type="other" id="sref56"><person-group person-group-type="author"><name name-style="western"><surname>Giamboy</surname><given-names>T.</given-names></name></person-group><article-title>A nursing-driven pathway to lung cancer screening; a push for prevention. Walden Dissertations and Doctoral Studies</article-title><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://scholarworks.waldenu.edu/dissertations/3990" id="intref0035">https://scholarworks.waldenu.edu/dissertations/3990</ext-link></element-citation></ref><ref id="bib57"><label>57</label><element-citation publication-type="journal" id="sref57"><person-group person-group-type="author"><name name-style="western"><surname>Balata</surname><given-names>H.</given-names></name><name name-style="western"><surname>Tonge</surname><given-names>J.</given-names></name><name name-style="western"><surname>Barber</surname><given-names>P.V.</given-names></name><etal/></person-group><article-title>Attendees of Manchester&#8217;s Lung Health Check pilot express a preference for community-based lung cancer screening</article-title><source>Thorax</source><volume>74</volume><year>2019</year><fpage>1176</fpage><lpage>1178</lpage><pub-id pub-id-type="pmid">31481631</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/thoraxjnl-2018-212601</pub-id></element-citation></ref><ref id="bib58"><label>58</label><element-citation publication-type="journal" id="sref58"><person-group person-group-type="author"><name name-style="western"><surname>Ruparel</surname><given-names>M.</given-names></name><name name-style="western"><surname>Quaife</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Ghimire</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Impact of a lung cancer screening information film on informed decision-making: A randomized trial</article-title><source>Ann Am Thorac Soc</source><volume>16</volume><year>2019</year><fpage>744</fpage><lpage>751</lpage><pub-id pub-id-type="pmid">31082267</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1513/AnnalsATS.201811-841OC</pub-id><pub-id pub-id-type="pmcid">PMC6543473</pub-id></element-citation></ref><ref id="bib59"><label>59</label><element-citation publication-type="journal" id="sref59"><person-group person-group-type="author"><name name-style="western"><surname>Grover</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ross</surname><given-names>T.</given-names></name><name name-style="western"><surname>Fuller</surname><given-names>E.</given-names></name></person-group><article-title>Implementation of targeted screening for lung cancer in a high-risk population within routine NHS practice using low-dose computed tomography</article-title><source>Thorax</source><volume>75</volume><year>2020</year><fpage>348</fpage><lpage>350</lpage><pub-id pub-id-type="pmid">32127463</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/thoraxjnl-2019-214303</pub-id></element-citation></ref><ref id="bib60"><label>60</label><element-citation publication-type="journal" id="sref60"><person-group person-group-type="author"><name name-style="western"><surname>Bartlett</surname><given-names>E.C.</given-names></name><name name-style="western"><surname>Kemp</surname><given-names>S.V.</given-names></name><name name-style="western"><surname>Ridge</surname><given-names>C.A.</given-names></name><etal/></person-group><article-title>Baseline Results of the West London lung cancer screening pilot study - Impact of mobile scanners and dual risk model utilisation</article-title><source>Lung Cancer</source><volume>148</volume><year>2020</year><fpage>12</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">32771715</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.lungcan.2020.07.027</pub-id></element-citation></ref><ref id="bib61"><label>61</label><element-citation publication-type="journal" id="sref61"><person-group person-group-type="author"><name name-style="western"><surname>Crosbie</surname><given-names>P.A.</given-names></name><name name-style="western"><surname>Balata</surname><given-names>H.</given-names></name><name name-style="western"><surname>Evison</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Implementing lung cancer screening: baseline results from a community-based &#8220;Lung Health Check&#8221; pilot in deprived areas of Manchester</article-title><source>Thorax</source><volume>74</volume><year>2019</year><fpage>405</fpage><lpage>409</lpage><pub-id pub-id-type="pmid">29440588</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/thoraxjnl-2017-211377</pub-id></element-citation></ref><ref id="bib62"><label>62</label><element-citation publication-type="journal" id="sref62"><person-group person-group-type="author"><name name-style="western"><surname>Quaife</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Ruparel</surname><given-names>M.</given-names></name><name name-style="western"><surname>Dickson</surname><given-names>J.L.</given-names></name><etal/></person-group><article-title>Lung screen uptake trial (LSUT): randomized controlled clinical trial testing targeted invitation materials</article-title><source>Am J Respir Crit Care Med</source><volume>201</volume><year>2020</year><fpage>965</fpage><lpage>975</lpage><pub-id pub-id-type="pmid">31825647</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/rccm.201905-0946OC</pub-id><pub-id pub-id-type="pmcid">PMC7159423</pub-id></element-citation></ref><ref id="bib63"><label>63</label><element-citation publication-type="journal" id="sref63"><person-group person-group-type="author"><name name-style="western"><surname>Ghimire</surname><given-names>B.</given-names></name><name name-style="western"><surname>Maroni</surname><given-names>R.</given-names></name><name name-style="western"><surname>Vulkan</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Evaluation of&#160;a&#160;health service adopting proactive approach to&#160;reduce high risk of lung cancer: the Liverpool Healthy Lung Programme</article-title><source>Lung Cancer</source><volume>134</volume><year>2019</year><fpage>66</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">31319997</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.lungcan.2019.05.026</pub-id></element-citation></ref><ref id="bib64"><label>64</label><element-citation publication-type="journal" id="sref64"><person-group person-group-type="author"><name name-style="western"><surname>Crosbie</surname><given-names>P.A.</given-names></name><name name-style="western"><surname>Balata</surname><given-names>H.</given-names></name><name name-style="western"><surname>Evison</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Second round results from the Manchester &#8220;Lung Health Check&#8221; community-based targeted lung cancer screening pilot</article-title><source>Thorax</source><volume>74</volume><year>2019</year><fpage>700</fpage><lpage>704</lpage><pub-id pub-id-type="pmid">30420406</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/thoraxjnl-2018-212547</pub-id><pub-id pub-id-type="pmcid">PMC6585285</pub-id></element-citation></ref><ref id="bib65"><label>65</label><element-citation publication-type="journal" id="sref65"><person-group person-group-type="author"><name name-style="western"><surname>Yoshida</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kondo</surname><given-names>K.</given-names></name><name name-style="western"><surname>Nakanishi</surname><given-names>C.</given-names></name><name name-style="western"><surname>Tada</surname><given-names>T.</given-names></name></person-group><article-title>Interventional study for improvement of lung cancer screening rate</article-title><source>J&#160;Med Invest</source><volume>59</volume><year>2012</year><fpage>127</fpage><lpage>135</lpage><pub-id pub-id-type="pmid">22450001</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2152/jmi.59.127</pub-id></element-citation></ref><ref id="bib66"><label>66</label><element-citation publication-type="journal" id="sref66"><person-group person-group-type="author"><name name-style="western"><surname>Veronesi</surname><given-names>G.</given-names></name><name name-style="western"><surname>Colombo</surname><given-names>P.</given-names></name><name name-style="western"><surname>Novellis</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Pilot study on use of home telephoning to identify and recruit high-risk individuals for lung cancer screening</article-title><source>Lung Cancer</source><volume>105</volume><year>2017</year><fpage>39</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">28236983</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.lungcan.2017.01.001</pub-id></element-citation></ref><ref id="bib67"><label>67</label><element-citation publication-type="journal" id="sref67"><person-group person-group-type="author"><name name-style="western"><surname>Sayani</surname><given-names>A.</given-names></name><name name-style="western"><surname>Manthorne</surname><given-names>J.</given-names></name><name name-style="western"><surname>Nicholson</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Toward equity-oriented cancer care: a Strategy for Patient-Oriented Research (SPOR) protocol to promote equitable access to lung cancer screening</article-title><source>Res Involvement Engagement</source><volume>8</volume><year>2022</year><fpage>11</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s40900-022-00344-y</pub-id><pub-id pub-id-type="pmcid">PMC8980795</pub-id><pub-id pub-id-type="pmid">35382905</pub-id></element-citation></ref><ref id="bib68"><label>68</label><element-citation publication-type="journal" id="sref68"><person-group person-group-type="author"><name name-style="western"><surname>Victora</surname><given-names>C.G.</given-names></name><name name-style="western"><surname>Fenn</surname><given-names>B.</given-names></name><name name-style="western"><surname>Bryce</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kirkwood</surname><given-names>B.R.</given-names></name></person-group><article-title>Co-coverage of preventive interventions and implications for child-survival strategies: evidence from national surveys</article-title><source>Lancet</source><volume>366</volume><year>2005</year><fpage>1460</fpage><lpage>1466</lpage><pub-id pub-id-type="pmid">16243091</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(05)67599-X</pub-id></element-citation></ref><ref id="bib69"><label>69</label><element-citation publication-type="other" id="sref69"><person-group person-group-type="author"><name name-style="western"><surname>White</surname><given-names>M.</given-names></name><name name-style="western"><surname>Adams</surname><given-names>J.</given-names></name><name name-style="western"><surname>Heywood</surname><given-names>P.</given-names></name></person-group><article-title>How and why do interventions that increase health overall widen inequalities within populations? Soc Inequal Public Health</article-title><comment>In press</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.universitypressscholarship.com/view/10.1332/policypress/9781847423207.001.0001/upso-9781847423207-chapter-5" id="intref0040">http://www.universitypressscholarship.com/view/10.1332/policypress/9781847423207.001.0001/upso-9781847423207-chapter-5</ext-link></element-citation></ref><ref id="bib70"><label>70</label><element-citation publication-type="journal" id="sref70"><person-group person-group-type="author"><name name-style="western"><surname>Frohlich</surname><given-names>K.L.</given-names></name><name name-style="western"><surname>Potvin</surname><given-names>L.</given-names></name></person-group><article-title>Transcending the known in public health practice: the inequality paradox: the population approach and vulnerable populations</article-title><source>Am J Public Health</source><volume>98</volume><year>2008</year><fpage>216</fpage><lpage>221</lpage><pub-id pub-id-type="pmid">18172133</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2105/AJPH.2007.114777</pub-id><pub-id pub-id-type="pmcid">PMC2376882</pub-id></element-citation></ref></ref-list><sec id="appsec1" sec-type="supplementary-material"><title>Supplementary Data</title><p id="p0190">
<supplementary-material content-type="local-data" id="mmc1" position="float" orientation="portrait"><caption><title>Supplementary Material 1</title></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mmc1.docx" position="float" orientation="portrait"/></supplementary-material>
<supplementary-material content-type="local-data" id="mmc2" position="float" orientation="portrait"><caption><title>Supplementary Material 2</title></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mmc2.docx" position="float" orientation="portrait"/></supplementary-material>
</p></sec><ack id="ack0010"><title>Acknowledgments</title><p id="p0185">This study is supported by grant number TLS- 170674, granted to Dr. Sayani from the <funding-source id="gs2"><institution-wrap><institution-id institution-id-type="doi">10.13039/501100000024</institution-id><institution>Canadian Institutes of Health Research</institution></institution-wrap></funding-source> as part of a Transition to Leadership Stream Patient-Oriented Research Award. The funding body had no role in the design of the study and the writing of the article. The authors also thank Alex Sadler and Christina Williams who contributed to the data search during their time as research students at Women&#8217;s College Hospital.</p></ack><fn-group><fn id="d35e3939"><p id="ntpara0010">Disclosure: Dr. Sayani reports receiving funding grants from the <funding-source id="gs1"><institution-wrap><institution-id institution-id-type="doi">10.13039/501100000024</institution-id><institution>Canadian Institutes of Health Research</institution></institution-wrap></funding-source>. Dr. Lofters reports to having a consulting or advisory relationship with Ontario Health. Ms. Nicholson is an employee of the Canadian Partnership Against Cancer. Ms. Corrado is an employee of the Women&#8217;s College Hospital.</p></fn><fn id="d35e3945"><p id="ntpara0015">Cite this article as: Sayani A, Ali MA, Dey P, et&#160;al. Interventions designed to increase the uptake of lung cancer screening: an equity-oriented scoping review. <italic toggle="yes">JTO Clin Res Rep.</italic> 2023;3:100469.</p></fn><fn id="appsec2" fn-type="supplementary-material"><p id="p0195">Note: To access the supplementary material accompanying this article, visit the online version of the <italic toggle="yes">JTO Clinical and Research Reports</italic> at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.jtocrr.org" id="intref0010">www.jtocrr.org</ext-link> and at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jtocrr.2023.100469" id="intref0015">https://doi.org/10.1016/j.jtocrr.2023.100469</ext-link>.</p></fn></fn-group></back></article></pmc-articleset>